JP3001694B2 - Benzene dioxygenase gene - Google Patents

Benzene dioxygenase gene

Info

Publication number
JP3001694B2
JP3001694B2 JP3284795A JP28479591A JP3001694B2 JP 3001694 B2 JP3001694 B2 JP 3001694B2 JP 3284795 A JP3284795 A JP 3284795A JP 28479591 A JP28479591 A JP 28479591A JP 3001694 B2 JP3001694 B2 JP 3001694B2
Authority
JP
Japan
Prior art keywords
ala
gly
leu
val
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP3284795A
Other languages
Japanese (ja)
Other versions
JPH053785A (en
Inventor
肇 西村
泰 川上
幸治 今村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mercian Corp
Original Assignee
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mercian Corp filed Critical Mercian Corp
Priority to JP3284795A priority Critical patent/JP3001694B2/en
Publication of JPH053785A publication Critical patent/JPH053785A/en
Application granted granted Critical
Publication of JP3001694B2 publication Critical patent/JP3001694B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、ベンゼンを酸化してシ
スベンゼングリコールを生成する酵素活性を宿主微生物
に付与する遺伝子を含むDNA、該DNAを含むプラス
ミド、及び該プラスミドで形質転換された微生物に関す
る。さらに本発明は、ベンゼンジオキシゲナーゼをコー
ドする遺伝子を含むDNA、及びベンゼンジオキシゲナ
ーゼを構成するポリペプチドに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a DNA containing a gene that confers an enzyme activity on a host microorganism to produce cisbenzene glycol by oxidizing benzene, a plasmid containing the DNA, and a microorganism transformed with the plasmid. About. Further, the present invention relates to DNA containing a gene encoding benzenedioxygenase, and a polypeptide constituting benzenedioxygenase.

【0002】[0002]

【従来の技術】シスベンゼングリコール(シス−1,2
−ジヒドロキシ−シクロヘキサ−3,5−ジエン)は、
エンジニアリングプラスチックとして最近特に注目を集
めているポリパラフェニレンの原料として有用な化合物
であり、生化学的には、カテコールを介してオルト−又
はメタ−パスウェイを経てTCAサイクルにより代謝さ
れる重要な化合物である。
2. Description of the Related Art Cisbenzene glycol (cis-1,2)
-Dihydroxy-cyclohexa-3,5-diene) is
It is a compound useful as a raw material for polyparaphenylene, which has recently attracted particular attention as an engineering plastic. Biochemically, it is an important compound that is metabolized by the TCA cycle via ortho- or meta-pathways via catechol. is there.

【0003】従来、微生物を利用してシスベンゼングリ
コールを製造する方法としては、シュードモナス属に属
する微生物をベンゼンを含む培地で培養してその培養物
からシスベンゼングリコールを採取する方法(特開昭5
8−71891号公報)が知られているが、該方法は効
率が悪く実用的ではなかった。一方、シスベンゼングリ
コールの生物学的代謝過程と類似の代謝過程により、ビ
フェニルを代謝する機能を有する外来遺伝子を保有する
微生物として、シュードモナス・プチダKF138株
(特開昭61−282068号公報)、シュードモナス
・エルギノーザKF257株(特開昭61−28206
9号公報)、及びシュードモナス・シュードアルカリゲ
ネスKF707株(特開昭61−282085号公報)
が知られているが、該微生物はビフェニルを資化する作
用を有するものの、ベンゼンに対して代謝作用を示して
シスベンゼングリコールを産生するものではなかった。
Conventionally, as a method for producing cis benzene glycol using a microorganism, there is a method of culturing a microorganism belonging to the genus Pseudomonas in a medium containing benzene and collecting cis benzene glycol from the culture (Japanese Patent Laid-Open No. Sho.
No. 8-71891), but the method is inefficient and not practical. On the other hand, as microorganisms having a foreign gene having a function of metabolizing biphenyl by a metabolic process similar to the biological metabolic process of cisbenzene glycol, Pseudomonas putida KF138 strain (JP-A-61-282068) and Pseudomonas -Elginosa KF257 strain (Japanese Unexamined Patent Publication No. 61-28206)
No. 9) and Pseudomonas pseudoalcaligenes KF707 strain (Japanese Patent Application Laid-Open No. Sho 61-282850).
Although these microorganisms have an activity of assimilating biphenyl, they did not produce cisbenzene glycol by exhibiting a metabolic effect on benzene.

【0004】[0004]

【発明が解決しようとする課題及び課題を解決するため
の手段】本発明者は、ベンゼンを酸化してシスベンゼン
グリコールを生成する機能を有するベンゼンジオキシゲ
ナーゼを保有する微生物から、該酵素をコードする遺伝
子を単離すべく鋭意努力した結果、シュードモナス・エ
ルギノーザに属する微生物からベンゼンジオキシゲナー
ゼをコードする遺伝子を単離することに成功し、本発明
を完成するに至った。すなわち、本発明はベンゼンジオ
キシゲナーゼ遺伝子、シスベンゼングリコールデヒドロ
ゲナーゼ遺伝子、及びカテコール 2,3−オキシゲナ
ーゼ遺伝子を含む約7.2KbのDNAであって、図1に
示す制限酵素地図を有することを特徴とするDNA、該
DNAを有する組み換えベクターDNA、該ベクターで
形質転換されベンゼンジオキシゲナーゼ、シスベンゼン
グリコールデヒドロゲナーゼ、及びカテコール 2,3
−オキシゲナーゼを産生する微生物と、ベンゼンジオキ
シゲナーゼ遺伝子を含む約5.6KbのDNAであって図
2に示す制限酵素地図を有することを特徴とするDN
A、該DNAを有する組み換えベクターDNA、及び該
ベクターで形質転換されベンゼンジオキシゲナーゼを産
生する微生物を提供するものである。また、本発明によ
り、ベンゼンジオキシゲナーゼをコードするDNA、及
びベンゼンジオキシゲナーゼを構成するポリペプチドが
提供される。
DISCLOSURE OF THE INVENTION The present inventors encode a benzenedioxygenase from a microorganism having a function of generating cisbenzene glycol by oxidizing benzene by encoding the enzyme. As a result of diligent efforts to isolate the gene, the inventors have succeeded in isolating a gene encoding benzenedioxygenase from a microorganism belonging to Pseudomonas aeruginosa, and have completed the present invention. That is, the present invention relates to an approximately 7.2 Kb DNA containing a benzenedioxygenase gene, a cisbenzeneglycol dehydrogenase gene, and a catechol 2,3-oxygenase gene, which has a restriction enzyme map shown in FIG. DNA, recombinant vector DNA having the DNA, benzenedioxygenase, cisbenzeneglycol dehydrogenase, and catechol transformed with the vector
A DNA producing an oxygenase-producing microorganism and a DNA of about 5.6 Kb containing a benzenedioxygenase gene and having a restriction map shown in FIG.
A, a recombinant vector DNA having the DNA, and a microorganism which is transformed with the vector and produces benzenedioxygenase. The present invention also provides a DNA encoding benzenedioxygenase and a polypeptide constituting benzenedioxygenase.

【0005】ベンゼンジオキシゲナーゼ遺伝子(BD
O)を含むDNAの供給源としては、ベンゼンを資化し
てシスベンゼングリコールを生産する能力を有する微生
物を利用することができ、この様な性質を有する微生物
のうち、例えばシュードモナス属に属する微生物を利用
することができる。シュードモナス属に属する微生物と
しては、例えばシュードモナス・エルギノーザJI10
4を使用することが好ましい。シュードモナス・エルギ
ノーザJI104は東京で採取された土壌から分離され
た微生物であり、工業技術院微生物工業技術研究所に平
成3年4月6日付けで受託番号微工研菌寄第12180
(FERM P−12180)として寄託されており、
菌学的性質は以下の通りである。
[0005] The benzenedioxygenase gene (BD
As a source of the DNA containing O), a microorganism having the ability to produce cisbenzene glycol by assimilating benzene can be used. Among microorganisms having such properties, for example, microorganisms belonging to the genus Pseudomonas can be used. Can be used. Examples of microorganisms belonging to the genus Pseudomonas include Pseudomonas aeruginosa JI10
Preferably, 4 is used. Pseudomonas aeruginosa JI104 is a microorganism isolated from soil collected in Tokyo, and has accession number No. 12180 to the Institute of Microbial Industry, National Institute of Advanced Industrial Science and Technology on April 6, 1991.
(FERM P-12180),
The mycological properties are as follows:

【0006】本菌は極鞭毛を有するグラム陰性の桿菌
で、運動性があり、絶対好気性かつ糖非発酵性である。
以上の性質と電子顕微鏡による観察から、本菌はシュー
ドモナス(Pseudomonas)属に属する微生物であると認め
られた。そこで、H. Oyaizu 及びK. Komagata の菌体脂
肪酸分析によるシュードモナスの分類を以下の様に行っ
た(J. Gen. Appl. Microbiol., 29, 17-14 (1983))。
The bacterium is a gram-negative bacillus having polar flagella, which is motile, absolutely aerobic, and non-fermenting sugar.
From the above properties and observation with an electron microscope, it was confirmed that the bacterium is a microorganism belonging to the genus Pseudomonas. Therefore, Pseudomonas was classified as follows by the analysis of bacterial fatty acids of H. Oyaizu and K. Komagata (J. Gen. Appl. Microbiol., 29 , 17-14 (1983)).

【0007】先ず、凍結乾燥菌体を5%NaOH/50%Me
OHを用いて100℃で1時間ケン化した後、抽出した脂
肪酸を15%BCl3-MeOH を用いて85℃で5分間メチル
エステル化し、次いでGLC分析を行った。ヒドロキシ
酸はTLC分析により確認した。 GLC分析:15% EGS(3.0φmm×2.1m )、180℃ TLC分析:silica gel 60 TLC (ジエチルエーテル:n−ヘキサン=1:4) 上記分析の結果、本菌の菌体脂肪酸成分は、12:0、
14:0、16:0、16:1、18:0、18:1、
Δ17、Δ19、3−OH・10:0、3−OH・12:0
(Trace)、2−OH・12:0から成ることが判明した。
この他に、15:0、17:0、19:0も微量検出さ
れた。これらの分析結果より、本菌がH.Oyaizu 及びK.
Komagata (J. Gen. Appl. Microbiol., 29, 17-14 (19
83))のGroup1に属することが確認された。このグルー
プには、シュードモナス・エルギノーザ(Pseudomonas
aeruginosa) 、P.プチダ(P.putida) 、P.オーレオファ
シエンス(P.aureofaciens) 、P.クロロラフィス(P.ch
lororaphis) 、P.フローレッセンス(P.fluoresces) 、
P.スツツェエ(P.stutzeri) 、及びP.メンドシーナ(P.
mendocina)等が包含されている。そして、本菌の菌体脂
肪酸成分から2−OH・12:0が検出されること、2−
OH・16:0が検出されないこと、Δ19が著量検出さ
れること等の特徴は、上記 Group1中のP.エルギノーザ
の菌体脂肪酸パターンに最も類似するものであった。本
菌の菌体よりDNAを抽出してDNAのG−C含量をT
m法で測定したところ、G−C含量は66.3モル%であ
った。この値はP.エルギノーザのG−C含量=67.2−
68.0モル%と比べるとやや低く、P.プチダのG−C含
量=62.5モル%とは明らかに異なるものであった。そ
こでシス−1,2−ジヒドロキシ−シクロヘキサ−3,
5−ジエン生産菌として既知のP.プチダと本菌の菌学的
性質を比較して、表1の結果を得た。
[0007] First, the freeze-dried microbial cells were treated with 5% NaOH / 50% Me.
After saponification with OH at 100 ° C. for 1 hour, the extracted fatty acid was methylesterified with 15% BCl 3 -MeOH at 85 ° C. for 5 minutes, and then subjected to GLC analysis. Hydroxy acids were confirmed by TLC analysis. GLC analysis: 15% EGS (3.0 φmm × 2.1 m), 180 ° C. TLC analysis: silica gel 60 TLC (diethyl ether: n-hexane = 1: 4) As a result of the above analysis, the fatty acid component of the bacterial cell was , 12: 0,
14: 0, 16: 0, 16: 1, 18: 0, 18: 1,
Δ17, Δ19, 3-OH · 10: 0, 3-OH · 12: 0
(Trace), 2-OH.12: 0.
In addition, trace amounts of 15: 0, 17: 0, and 19: 0 were also detected. Based on these analysis results, this bacterium was found to be H. Oyaizu and K.
Komagata (J. Gen. Appl. Microbiol., 29 , 17-14 (19
83)) It was confirmed to belong to Group 1. This group includes Pseudomonas aeruginosa (Pseudomonas
aeruginosa), P. putida, P. aureofaciens, P. chlororafis (P. ch)
lororaphis), P. floresces,
P. stutzeri and P. mendocina
mendocina) and the like. Then, 2-OH · 12: 0 is detected from the fatty acid component of the bacterial cell,
The characteristics such as OH · 16: 0 not being detected and Δ19 being detected in a significant amount were the most similar to the bacterial fatty acid pattern of P. aeruginosa in Group 1 described above. DNA is extracted from the cells of this bacterium and the GC content of the DNA is determined by T
As measured by the m method, the GC content was 66.3 mol%. This value is the GC content of P. aeruginosa = 67.2-
This was slightly lower than 68.0 mol%, which was clearly different from the GC content of P. putida = 62.5 mol%. Therefore, cis-1,2-dihydroxy-cyclohexa-3,
The results of Table 1 were obtained by comparing the mycological properties of P. putida, which is known as a 5-diene-producing bacterium, with this bacterium.

【0008】 表 1 ──────────────────── 分離菌 ──────────────────── I.形 態 グラム染色性 陰 性 運動性 有 鞭 毛 極−1 ──────────────────── II.生理学的性質 色素の生成 蛍光色素 − ピオシアニン − カロチノイド ピンク 生育(41℃) ± オキシダーゼ反応 + 脱窒反応 + ゼラチンの水解 − 澱粉の水解 − ──────────────────── III.生 育 グルコース + マルトース ± シュークロース − マンニトール − グリセロール + L−リンゴ酸 + 酒石酸 − コハク酸 + マロン酸 − ベタイン + ザルコシン + ゲラニオール + β−アラニン + DL−アルギニン + L−セリン − チロシン + ──────────────────── 但し、+:陽性 −:陰性 これらの結果から明らかなように、本菌はP.プチダとは
明確に区別され、最も類似した菌はP.エルギノーサであ
る。しかしながら、本分離菌は、特にゼラチンの加水分
解、マンニトール、マロン酸等に対する挙動がP.エルギ
ノーサと異なっており、G−C含量もP.エルギノーサと
比べてやや低く、菌体が僅かにピンク色を呈するなど微
妙な相違点も認められることから、本菌をP.エルギノー
サの新変種であると同定した。
Table 1 {Isolated Bacteria} Morphology Gram stain Negative motility Flagella flagella-1 II II. Physiological properties Dye formation Fluorescent dye-pyocyanin-carotenoid pink Growth (41 ° C) ± oxidase reaction + denitrification reaction + gelatin hydrolysis-starch hydrolysis-──────────────── III. Growth glucose + maltose ± sucrose-mannitol-glycerol + L-malic acid + tartaric acid-succinic acid + malonic acid-betaine + sarcosine + geraniol + β-alanine + DL-arginine + L-serine-tyrosine + ──── ──────────────── However, +: positive-: negative As is clear from these results, this bacterium is clearly distinguished from P. putida and is the most similar bacterium. Is P. aeruginosa. However, this isolated bacterium is different from P. aeruginosa particularly in the behavior of gelatin for hydrolysis, mannitol, malonic acid, etc., has a slightly lower GC content than P. aeruginosa, and has a slightly pink cell. This strain was identified as a new variant of P. aeruginosa, since subtle differences were also observed.

【0009】ベンゼンを資化してシスベンゼングリコー
ルを生産する能力を有する微生物からベンゼンジオキシ
ゲナーゼ遺伝子(BDO)を含む遺伝子を切り出すに
は、例えば以下の方法によればよい。ベンゼン資化能を
有する上記の微生物を適当な培地、例えばLB培地(1
リットル中にトリプトン10g/酵母エキス5g/塩化
ナトリウム5gを含む)等で培養した後、例えばリゾチ
ームを用いて菌体を融解して常法により染色体DNAを
調製し、例えば制限酵素XhoIで消化することにより
ベンゼンジオキシゲナーゼ遺伝子を含む約7.2KbのD
NA断片(NKKI1)を得ることができる。この様に
して得たDNA断片を、制限酵素XhoIで消化したベ
クター、例えばプラスミドベクターであるpHSG39
6とライゲーションし、例えばハナハン法によりコンピ
テントセルとした大腸菌HB101に該組み換えベクタ
ーを導入して形質転換体を得、その後に適当な選択手
段、例えばクロラムフェニコールを含むLB培地で培養
することにより形質転換株を選択することができる。
The following method can be used to cut out a gene containing the benzenedioxygenase gene (BDO) from a microorganism capable of producing cis benzene glycol by utilizing benzene. The above-mentioned microorganisms having benzene assimilation ability are converted into an appropriate medium, for example, an LB medium (1.
After culturing with 10 g of tryptone / 5 g of yeast extract / 5 g of sodium chloride in a liter, for example, the cells are thawed using, for example, lysozyme to prepare chromosomal DNA by a conventional method, and digested with, for example, a restriction enzyme XhoI. Approximately 7.2 Kb of D containing the benzenedioxygenase gene
An NA fragment (NKKI1) can be obtained. The DNA fragment thus obtained is digested with a restriction enzyme XhoI, for example, a plasmid vector pHSG39.
6 and ligated with E. coli HB101 transformed into competent cells by the Hanahan method to obtain a transformant, for example, followed by culturing in an LB medium containing chloramphenicol by appropriate selection means, for example, chloramphenicol. To select a transformant.

【0010】上記の形質転換株からベンゼンジオキシゲ
ナーゼ遺伝子を含む組み換えベクターを有する形質転換
株を選択するには、形質転換株を培養後にカテコールを
散布して黄色を呈するコロニーを選択すればよい。これ
はベンゼンオキシゲナーゼの遺伝子と同じ遺伝子領域に
あるカテコール 2,3−オキシゲナーゼを選択するも
のであり、カテコールがカテコール 2,3−オキシゲ
ナーゼで酸化された結果生成する2−ヒドロキシムコン
酸6−セミアルデヒドが黄色を呈することを利用するも
のである。この様にして選択された形質転換体として、
例えば大腸菌HB101/pXCY−Bpを挙げること
ができる。大腸菌HB101/pXCY−Bpは、ベン
ゼンジオキシゲナーゼ遺伝子を含む約7.2KbのDNA
断片(NKKI1)を含む組み換えプラスミドpXCY
−Bpにより形質転換された微生物であり、工業技術院
微生物工業技術研究所に平成3年4月6日付けで受託番
号微工研菌寄第12178号(FERM P−1217
8)として寄託されている。
To select a transformant having the recombinant vector containing the benzenedioxygenase gene from the above transformants, cultivating the transformant and spraying catechol thereon to select a yellow colony. This selects catechol 2,3-oxygenase in the same gene region as the benzene oxygenase gene, and 2-hydroxymuconic acid 6-semialdehyde produced as a result of catechol being oxidized by catechol 2,3-oxygenase. This is to utilize the appearance of yellow. As a transformant selected in this way,
For example, Escherichia coli HB101 / pXCY-Bp can be mentioned. E. coli HB101 / pXCY-Bp is a DNA of about 7.2 Kb containing a benzenedioxygenase gene.
Recombinant plasmid pXCY containing fragment (NKKI1)
-Bp transformed microorganism, and submitted to the Institute of Microbial Industry and Technology of the National Institute of Advanced Industrial Science and Technology on April 6, 1991 under the accession number of Microtechnical Laboratory No. 12178 (FERM P-1217).
8).

【0011】プラスミドpXCY−Bpに挿入されたN
KKI1は、ベンゼンジオキシゲナーゼ遺伝子(BD
O)、シスベンゼングリコールデヒドロゲナーゼ遺伝子
(cBDH)、及びカテコール 2,3−オキシゲナー
ゼ遺伝子(C23O)を含む約7.2KbのDNAであ
り、該NKKI1を消化する制限酵素の切断数はPst
I:6; EcoRI:2; SmaI:1; Sal
I:5; BglII:1; BamHI:2; Sa
cI:1; XhoI:1;XbaI:0; Hind
III:0; KpnI:0; SphI:6; 及び
ClaI:1であり、NKKI1の制限酵素地図及び遺
伝子のベンゼン代謝様式と遺伝子群との関係は図1に示
す通りである。ベンゼンジオキシゲナーゼ遺伝子として
は特願昭62−278985号公報に記載されたものが
知られているが、上記のNKKI1は上記公報に記載さ
れたものとは異なる制限酵素地図を有するものである。
The N inserted into the plasmid pXCY-Bp
KKI1 is a benzenedioxygenase gene (BD
O), about 7.2 Kb of DNA containing the cisbenzene glycol dehydrogenase gene (cBDH) and the catechol 2,3-oxygenase gene (C23O), and the number of restriction enzymes digesting NKKI1 is Pst
I: 6; EcoRI: 2; SmaI: 1; Sal
I: 5; BglII: 1; BamHI: 2; Sa
XhoI: 1; XbaI: 0; Hind
III: 0; KpnI: 0; SphI: 6; and ClaI: 1. The relationship between the restriction enzyme map of NKKI1 and the benzene metabolism mode of the gene and the gene group is as shown in FIG. As the benzenedioxygenase gene, a gene described in Japanese Patent Application No. 62-278985 is known, but the above-mentioned NKKI1 has a restriction enzyme map different from that described in the above publication.

【0012】この様にして得られたプラスミドpXCY
−Bp中のカテコール 2,3−オキシゲナーゼ及びシ
スベンゼングリコールデヒドロゲナーゼをコードする遺
伝子をエキソヌクレアーゼExoIII により除去するこ
とにより、ベンゼンジオキシゲナーゼ遺伝子のみを含む
DNA断片、例えばNKKI1−1(約5.6Kb)を得
ることができる。上記のNKKI1(約7.2Kb)を制
限酵素KpnI及びXbaIで消化した後にエキソヌク
レアーゼExoIII で処理し、マングビーンヌクレアー
ゼで処理してDNAの1本鎖部分を除去し、その後にク
レノウフラグメントを加えてDNA末端の平滑化を行
い、常法に従ってライゲーションすることにより、ベン
ゼンジオキシゲナーゼ遺伝子を有する組み換えプラスミ
ドを得ることができる。この様なプラスミドとしてプラ
スミドpBPT8−1を挙げることができ、該プラスミ
ドを用いて常法により形質転換された形質転換体を、前
記の方法により選択することにより大腸菌HB101/
pBPT8−1を得ることができる。大腸菌HB101
/pBPT8−1は、ベンゼンジオキシゲナーゼ遺伝子
を含む約5.6KbのDNA断片(NKKI1−1)を含
むプラスミドpBPT8−1により形質転換された微生
物であり、工業技術院微生物工業技術研究所に平成3年
4月6日付けで受託番号微工研菌寄第12179(FE
RM P−12179)として寄託されている。
The thus obtained plasmid pXCY
By removing the genes encoding catechol 2,3-oxygenase and cisbenzene glycol dehydrogenase in Bp with exonuclease ExoIII, a DNA fragment containing only the benzenedioxygenase gene, for example, NKKI1-1 (about 5.6 Kb) is obtained. Obtainable. The above-mentioned NKKI1 (about 7.2 Kb) is digested with restriction enzymes KpnI and XbaI, treated with exonuclease ExoIII, treated with mung bean nuclease to remove a single-stranded portion of DNA, and then Klenow fragment is added. Then, the DNA ends are blunted and ligated according to a conventional method to obtain a recombinant plasmid having a benzenedioxygenase gene. Plasmid pBPT8-1 can be mentioned as such a plasmid, and a transformant transformed by a conventional method using the plasmid is selected by the above-described method to obtain Escherichia coli HB101 /
pBPT8-1 can be obtained. Escherichia coli HB101
/ PBPT8-1 is a microorganism transformed with a plasmid pBPT8-1 containing a DNA fragment (NKKI1-1) of about 5.6 Kb containing a benzenedioxygenase gene. Accession No. 12179 (FE)
RM P-12179).

【0013】プラスミドpBPT8−1に挿入されたN
KKI1−1は、ベンゼンジオキシゲナーゼ遺伝子(B
DO)を含む約5.6KbのDNAであり、該NKKI1
−1を消化する制限酵素の切断数はPstI:4; E
coRI:2; SmaI:1; SalI:5; B
glII:1; BamHI:2;SacI:1;Xh
oI:1; XbaI:0; HindIII:0;
KpnI:0;SphI:6; 及びClaI:0であ
り、NKKI1−1の制限酵素地図は図2に示す通りで
ある。
The N inserted into plasmid pBPT8-1
KKI1-1 is a benzenedioxygenase gene (B
DO) and about 5.6 Kb of DNA.
-1 digestion number of restriction enzymes is PstI: 4; E
coRI: 2; SmaI: 1; SalI: 5; B
glII: 1; BamHI: 2; SacI: 1; Xh
oI: 1; XbaI: 0; HindIII: 0;
KpnI: 0; SphI: 6; and ClaI: 0, and the restriction map of NKKI1-1 is as shown in FIG.

【0014】この様にして得た形質転換体を利用するこ
とによりベンゼンからシスベンゼングリコールを効率よ
く製造することができる。例えば、形質転換された微生
物を例えばM56等の培地中で、でエタノール、酢酸、
グルコース、乳酸等のエネルギー源およびベンゼンの存
在下、好ましくはベンゼンの蒸気下に培養することによ
り培地中にシスベンゼングリコールが製造される。反応
は25〜42℃、好ましくは37℃で通常2〜24時間
行えばよく、原料となるベンゼンの濃度は培養液の全量
に対して0.07〜0.2%程度とすればよい。反応終了後
に、培養液からエーテル、塩化メチレン等を用いて抽出
することによりシスベンゼングリコールを効率よく製造
することができる。
By using the transformant thus obtained, cis benzene glycol can be efficiently produced from benzene. For example, a transformed microorganism is cultured in a medium such as M56 with ethanol, acetic acid,
By culturing in the presence of an energy source such as glucose or lactic acid and benzene, preferably in the vapor of benzene, cisbenzene glycol is produced in the medium. The reaction may be performed at 25 to 42 ° C., preferably 37 ° C., usually for 2 to 24 hours, and the concentration of benzene as a raw material may be about 0.07 to 0.2% based on the total amount of the culture solution. After completion of the reaction, cisbenzene glycol can be efficiently produced by extracting the culture solution with ether, methylene chloride or the like.

【0015】[0015]

【発明の効果】ベンゼンの酸化によるシスベンゼングリ
コールの製造に有用なベンゼンジオキシゲナーゼをコー
ドする遺伝子、及びシスベンゼングリコールを効率よく
産生する能力を有する微生物が提供された。また、該微
生物を利用することによりシスベンゼングリコールを安
価に製造することが可能になった。
As described above, a gene encoding benzenedioxygenase useful for producing cisbenzene glycol by oxidizing benzene and a microorganism having an ability to efficiently produce cisbenzeneglycol are provided. In addition, it has become possible to produce cis benzene glycol at low cost by utilizing the microorganism.

【0016】[0016]

【実施例】以下に本発明を実施例によりさらに具体的に
説明するが、本発明はこれらの実施例に限定されない。 実施例1 ベンゼン資化能を有するシュードモナス・エルギノーザ
JI104株を100mlのLB培地(1リットル中にト
リプトン10g/酵母エキス5g/塩化ナトリウム5g
を含む)で一晩培養した後に集菌して50mMリン酸緩衝
液で洗浄した後に、菌体に10mlのSTE(10mMトリ
ス(pH7.5)/1mMEDTA/100mM塩化ナトリウ
ム)と5mMのリゾチームを加えて37℃で30分間イン
キュベートし、その後に−80℃で30分間凍結した。
菌体を融解し、0.8%サルコシルを含む20mlのSTE
と10mgのプロナーゼEを加えて37℃で1時間インキ
ュベートした後にフェノール処理とエタノール沈澱を行
った。得られたDNAから多糖類を除いた後、さらにフ
ェノール処理とエタノール沈澱を行い、得られたDNA
を10mMトリス/1mMEDTA緩衝液に懸濁した。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. Example 1 A Pseudomonas aeruginosa JI104 strain capable of assimilating benzene was added to 100 ml of an LB medium (10 g of tryptone / 5 g of yeast extract / 5 g of sodium chloride per liter).
After overnight culture, the cells were collected, washed with 50 mM phosphate buffer, and 10 ml of STE (10 mM Tris (pH 7.5) / 1 mM EDTA / 100 mM sodium chloride) and 5 mM lysozyme were added to the cells. And incubated at 37 ° C for 30 minutes, followed by freezing at -80 ° C for 30 minutes.
Thaw the cells and add 20 ml of STE containing 0.8% sarkosyl.
And 10 mg of Pronase E were added and incubated at 37 ° C. for 1 hour, followed by phenol treatment and ethanol precipitation. After removing the polysaccharide from the obtained DNA, the DNA was further subjected to phenol treatment and ethanol precipitation to obtain the obtained DNA.
Was suspended in 10 mM Tris / 1 mM EDTA buffer.

【0017】得られたDNAを制限酵素Sau3AI
(Y−100緩衝液:10mMトリス(pH7.5)/10mM
塩化マグネシウム/100mM塩化ナトリウム/6mMメル
カプトエタノールを含む)を用いて37℃で30分間処
理して部分消化し、0.8%アガロースゲル電気泳動によ
って5Kbから7KbのDNA断片を切り出した。この
DNA断片と制限酵素BamHIで消化したプラスミド
pUC19とライゲーションを行い、得られた組み換え
プラスミドpCY13を、宿主である大腸菌HB101
に導入してアンピシリン50μg/mlを含むLB培地で
成育可能な形質転換体を得た。
The obtained DNA was subjected to restriction enzyme Sau3AI.
(Y-100 buffer: 10 mM Tris (pH 7.5) / 10 mM
The mixture was treated at 37 ° C. for 30 minutes with magnesium chloride / 100 mM sodium chloride / 6 mM mercaptoethanol for partial digestion, and a 5 Kb to 7 Kb DNA fragment was cut out by 0.8% agarose gel electrophoresis. This DNA fragment was ligated with the plasmid pUC19 digested with the restriction enzyme BamHI, and the resulting recombinant plasmid pCY13 was transformed into the host E. coli HB101.
To obtain a transformant capable of growing on an LB medium containing 50 μg / ml of ampicillin.

【0018】この培地上のコロニーに対しカテコール5
0mMを噴霧して黄変するコロニーを選択した。該コロニ
ーを培養することにより得られた菌体からカテコール
2,3−オキシゲナーゼ遺伝子を有するプラスミドpC
Y13を抽出し、ジデオキシ法により塩基配列を決定し
た。これによりカテコール 2,3−オキシゲナーゼ遺
伝子の遺伝子上での向きを明らかにし、pCY13に挿
入されたDNAの5’上流をプローブとして、シュード
モナス・エルギノーザJI104より抽出したDNAを
種々の制限酵素で消化したものを、1.0%アガロースゲ
ル電気泳動によりサザンブロティングを行った。この結
果、制限酵素XhoIによって消化される約7KbのD
NA断片中にカテコール 2,3−オキシゲナーゼ及び
その上流を含むオペロンが含まれていることが推定され
た。
Catechol 5 was used for colonies on this medium.
A yellowing colony was selected by spraying with 0 mM. Catechol was obtained from the cells obtained by culturing the colonies.
Plasmid pC having 2,3-oxygenase gene
Y13 was extracted and its nucleotide sequence was determined by the dideoxy method. Thus, the orientation of the catechol 2,3-oxygenase gene on the gene was clarified, and the DNA extracted from Pseudomonas aeruginosa JI104 was digested with various restriction enzymes using the 5 ′ upstream of the DNA inserted into pCY13 as a probe. Was subjected to Southern blotting by 1.0% agarose gel electrophoresis. This results in about 7 Kb of D digested by the restriction enzyme XhoI.
It was estimated that the operon containing catechol 2,3-oxygenase and its upstream was contained in the NA fragment.

【0019】シュードモナス・エルギノーザJI104
染色体DNAを制限酵素XhoIで消化し、0.8%アガ
ロースゲルで電気泳動後、6Kbから8KbのDNA断
片を切り出し、制限酵素XhoIで消化したプラスミド
pHSG396とライゲーションし、得られた組み換え
プラスミドを大腸菌HB101に導入してクロラムフェ
ニコール34μg/mlを含むLB培地で培養し形質転換
株を選択した。この培地上のコロニーにカテコール50
mMを噴霧して黄変するコロニーを選択した。選択された
形質転換株を5mlのLB培地で一晩培養した後に集菌、
洗浄し、プロリン20μg/mlとコハク酸5g/リット
ルを含むM56培地(水1リットル中にNa2HPO4.7H2O
8.2g/KH2PO4 2.7g/(NH2)2SO4 1.0g/FeSO4.7H2O 0.23mg
を含む)に再懸濁して、ベンゼン蒸気下に37℃で2時
間培養した後に1mlを回収した。遠心分離により大腸菌
を除き、さらに限外濾過によって分子量10,000以
上の高分子を除いた後、HPLCによってシスベンゼン
グリコール及びカテコールの生産を確認した。形質転換
株からプラスミドpXCY−Bpを抽出して制限酵素処
理、0.8%アガロースゲル電気泳動、6%アクリリルア
ミドゲル電気泳動によってNKKI1の制限酵素地図を
作成した(図1参照)。
Pseudomonas aeruginosa JI104
The chromosomal DNA was digested with restriction enzyme XhoI, electrophoresed on a 0.8% agarose gel, a DNA fragment of 6 Kb to 8 Kb was cut out, ligated with plasmid pHSG396 digested with restriction enzyme XhoI, and the obtained recombinant plasmid was transformed into Escherichia coli HB101. And cultured in an LB medium containing 34 μg / ml of chloramphenicol to select a transformant. Catechol 50 was added to the colonies on this medium.
The yellowing colonies were selected by spraying mM. After culturing the selected transformant overnight in 5 ml of LB medium, collecting cells,
Washed, the M56 medium (1 liter of water containing proline 20 [mu] g / ml and succinic acid 5 g / l Na 2 HPO 4 .7H 2 O
8.2g / KH 2 PO 4 2.7g / (NH 2) 2 SO 4 1.0g / FeSO 4 .7H 2 O 0.23mg
) And cultured at 37 ° C. for 2 hours under benzene vapor, and 1 ml was recovered. After removing Escherichia coli by centrifugation and removing polymers having a molecular weight of 10,000 or more by ultrafiltration, the production of cisbenzene glycol and catechol was confirmed by HPLC. Plasmid pXCY-Bp was extracted from the transformant, treated with restriction enzymes, 0.8% agarose gel electrophoresis, and 6% acrylylamide gel electrophoresis to prepare a restriction map of NKKI1 (see FIG. 1).

【0020】さらにベンゼンジオキシゲナーゼ遺伝子を
含む挿入DNA断片(NKKI1−1:5.6Kb)を組
み込んだプラスミドpBPT8−1を以下の様に作成し
た。5μgのプラスミドpXCY−Bpを制限酵素Kp
nI及びXbaIで消化した後、フェノール処理とエタ
ノール沈澱を行い、エキソヌクレアーゼExoIII 緩衝
液(50mMトリス/1mM塩化マグネシウム/1mM2−メ
ルカプトエタノール)に懸濁し、150ユニットのエキ
ソヌクレアーゼExoIII を加えて37℃で5分間イン
キュベートした、その後65℃で5分間インキュベート
してエキソヌクレアーゼExoIII を失活させた。さら
に等量のマングビーンヌクレアーゼ緩衝液(60mM酢酸
ナトリウム/100mM塩化ナトリウム/2mM酢酸亜鉛/
10%グリセリン)及び5ユニットのマングビーンヌク
レアーゼを加えて37℃で1時間インキュベートしてD
NAの1本鎖部分の除去を行った。さらにフェノール処
理とエタノール沈澱を行ったうえで、クレノウフラグメ
ント緩衝液(67mMリン酸カリウム/6.7mM塩化マグネ
シウム/1mM2−メルカプトエタノール/33μMdN
TP)に懸濁し、5ユニットのクレノウフラグメントを
加え37℃で15分間インキュベートしてDNA末端の
平滑化を行い、常法に従ってライゲーションし、大腸菌
HB101に導入した。尚、NKKI1−1の制限酵素
地図は図2に示す通りである。 実施例2 ベンゼンジオキシゲナーゼ遺伝子を含むプラスミドpB
PT8−1で形質転換された大腸菌HB101を、5ml
のLB培地を用いて37℃で一晩培養した。4×109
セル/mlのHB101を集菌して洗浄し、20μg/ml
のプロリンと5g/リットルのコハク酸を含む5mlのM
56培地に再懸濁した。ベンゼン蒸気下で22時間培養
し、遠心分離、限外濾過によって精製して、HPLCに
よりシスベンゼングリコールの濃度を測定し(OD27
5nm)、シスベンゼングリコールが生産されたことを確
認した。 実施例3 上記のNKKI1−1の塩基配列は以下の様にして決定
した。NKKI1−1を各制限酵素により切り出した後
にM13プラスミドに組み換え、またはNKKI1−1
をキロシーケンス法により削り縮めたサンプルを作製
し、ベンゼンジオキシゲナーゼをコードする4.7kbにつ
いてジデオキシ法により塩基配列を決定した。組み換え
DNA作製法、キロシーケンス法、ジデオキシ法につい
ては常法に従った。その結果、ベンゼンジオキシゲナー
ゼをコードするDNAの配列は、以下に示す様に、5つ
のコード領域を含む4721塩基配列であることが明らかに
なった。
Further, a plasmid pBPT8-1 incorporating an inserted DNA fragment (NKKI1-1: 5.6 Kb) containing a benzenedioxygenase gene was prepared as follows. 5 μg of plasmid pXCY-Bp was replaced with restriction enzyme Kp
After digestion with nI and XbaI, phenol treatment and ethanol precipitation were performed, suspended in exonuclease ExoIII buffer (50 mM Tris / 1 mM magnesium chloride / 1 mM 2-mercaptoethanol), and 150 units of exonuclease ExoIII was added thereto. Incubation was performed for 5 minutes and then at 65 ° C. for 5 minutes to inactivate the exonuclease ExoIII. Further, an equal amount of mung bean nuclease buffer (60 mM sodium acetate / 100 mM sodium chloride / 2 mM zinc acetate /
10% glycerin) and 5 units of mung bean nuclease and incubate at 37 ° C. for 1 hour to give D
Removal of the single-stranded portion of NA was performed. After phenol treatment and ethanol precipitation, Klenow fragment buffer (67 mM potassium phosphate / 6.7 mM magnesium chloride / 1 mM 2-mercaptoethanol / 33 μM dN
TP), 5 units of Klenow fragment were added, and the mixture was incubated at 37 ° C. for 15 minutes to blunt DNA ends, ligated according to a conventional method, and introduced into E. coli HB101. The restriction map of NKKI1-1 is as shown in FIG. Example 2 Plasmid pB containing benzenedioxygenase gene
5 ml of E. coli HB101 transformed with PT8-1
Was cultured overnight at 37 ° C. using LB medium. 4 × 10 9
Cells / ml of HB101 are collected and washed, and 20 μg / ml
Of proline and 5 ml of M containing 5 g / l of succinic acid
Resuspended in 56 medium. The cells were cultured under benzene vapor for 22 hours, purified by centrifugation and ultrafiltration, and the concentration of cisbenzene glycol was measured by HPLC (OD27
5 nm), and it was confirmed that cisbenzene glycol was produced. Example 3 The nucleotide sequence of NKKI1-1 was determined as follows. NKKI1-1 was excised with each restriction enzyme and then recombined into M13 plasmid or NKKI1-1.
Was cut by the kilosequence method to prepare a sample, and the nucleotide sequence of 4.7 kb encoding benzenedioxygenase was determined by the dideoxy method. The recombinant DNA production method, kilosequence method, and dideoxy method followed conventional methods. As a result, it was revealed that the sequence of the DNA encoding benzenedioxygenase was a 4721 base sequence including five coding regions, as shown below.

【0021】[0021]

【化3】 Embedded image

【0022】該配列において、領域IVと領域Vの間は、
領域IVをコードする配列が3411番目から3413番目の終止
コドンで終了し、領域Vをコードする配列は3410番目か
ら3412番目の開始コドンで開始するため、下記の様に一
部DNAが2重に読み込まれる。
In the sequence, between the region IV and the region V,
Since the sequence encoding region IV ends at the 3411th to 3413th stop codon, and the sequence encoding region V starts at the 3410th to 3412th start codon, the DNA is partially doubled as described below. Is read.

【0023】[0023]

【化4】 Embedded image

【0024】このため、以下の配列表においては、3408
番目から3409番目の塩基によりコードされるアミノ酸を
Proとして表示してある。
For this reason, in the following sequence listing, 3408
The amino acid encoded by the 3rd to 3409th bases is indicated as Pro.

【0025】[0025]

【配列表】配列の長さ:7421 配列の型:核酸 鎖の数:二本鎖 トポロジー:直鎖状 配列の種類:Genomic DNA 起源: 生物名:シュート゛モナス エルキ゛ノーサ゛ (Pseudomonas aeruginosa) 株名:JI104 配列の特徴 特徴を表す記号:−10 signal 存在位置:479..484 特徴を決定した方法:S 特徴を表す記号:−35 signal 存在位置:455..460 特徴を決定した方法:S 配列 CTCGAGAGCG AATGTACGCC AAAGCGTGCT GAATGGTGAC GCTGAATGGG AGGCGCGGAT 60 CGTCAGTTCG TTTCACCGAC TGTCATTGAT TGAAGAGCCC ACGATGCGGG ATCCGGCTCG 120 CTGGTTTAAT GAGTGGGAGC CAGTCAACCG CCGGTTTTCA CGAAGCTCTT ATCTCTGCCC 180 TGTTCGTCCG TCTGGATCCG GCGGTTCCTG TCCATCCTGT ATGTGCATAT GGAGCGCTAC 240 CGCCGATTGA CTGCTATGCA CAACCCGCCT ACCAGAAACG TACATGAGGA GCATCTAGCA 300 CTTCGCGACA GCCGCTCGCC GGAGATGCCG AGCGCTGTGC TGCGTTGATG GCGGAGCACA 360 TCGAATCATC AATTTCGGTG GTTCGGGAAT TCGGTTTGTT GAGGTGACGC CAACATCCCA 420 CGTGTTTGTT TTCGTCGTGA TGGATGCGGT CGGCATTTTT TCGCCCTACT AAGGGCATTT 480 CAAAGGAGAC GTTGAATC 498 ATG AGC TCA TCA ATC AAA GAA GTG CAG GGA GCC CCT GTG AAG TGG GTT 546 Met Ser Ser Ser Ile Lys Glu Val Gln Gly Ala Pro Val Lys Trp Val 1 5 10 15 ACC AAT TGG ACG CCG GAG GCG ATC CGG GGG TTG GTC GAT CAG GAA AAA 594 Thr Asn Trp Thr Pro Glu Ala Ile Arg Gly Leu Val Asp Gln Glu Lys 20 25 30 GGG CTG CTT GAT CCA CGC ATC TAC GCC GAT CAG AGT CTT TAT GAG CTG 642 Gly Leu Leu Asp Pro Arg Ile Tyr Ala Asp Gln Ser Leu Tyr Glu Leu 35 40 45 GAG CTT GAG CGG GTT TTT GGT CGC TCT TGG CTG TTA CTT GGG CAC GAG 690 Glu Leu Glu Arg Val Phe Gly Arg Ser Trp Leu Leu Leu Gly His Glu 50 55 60 AGT CAT GTG CCT GAA ACC GGG GAC TTC CTG GCC ACT TAC ATG GGC GAA 738 Ser His Val Pro Glu Thr Gly Asp Phe Leu Ala Thr Tyr Met Gly Glu 65 70 75 80 GAT CCG GTG GTT ATG GTG CGA CAG AAA GAC AAG AGC ATC AAG GTG TTC 786 Asp Pro Val Val Met Val Arg Gln Lys Asp Lys Ser Ile Lys Val Phe 85 90 95 CTG AAC CAG TGC CGC GGC ATG CGT ATC TGC CGC TCG GAC GCC GGC AAC 834 Leu Asn Gln Cys Arg Gly Met Arg Ile Cys Arg Ser Asp Ala Gly Asn 100 105 110 GCC AAG GCT TTC ACC TGC AGC TAT CAC GGC TGG GCC TAC GAC ATC GCC 882 Ala Lys Ala Phe Thr Cys Ser Tyr His Gly Trp Ala Tyr Asp Ile Ala 115 120 125 GGC AAG CTG GTG AAC GTG CCG TTC GAG AAG GAA GCC TTT TGC GAC AAG 930 Gly Lys Leu Val Asn Val Pro Phe Glu Lys Glu Ala Phe Cys Asp Lys 130 135 140 AAA GAA GGC GAC TGC GGC TTT GAC AAG GCC GAA TGG GGC CCG CTC CAG 978 Lys Glu Gly Asp Cys Gly Phe Asp Lys Ala Glu Trp Gly Pro Leu Gln 145 150 155 160 GCA CGC GTG GCA ACC TAC AAG GGC CTG GTC TTT GCC AAC TGG GAT GTG 1026 Ala Arg Val Ala Thr Tyr Lys Gly Leu Val Phe Ala Asn Trp Asp Val 165 170 175 CAG GCG CCA GAC CTG GAG ACC TAC CTC GGT GAC GCC CGC CCC TAT ATG 1074 Gln Ala Pro Asp Leu Glu Thr Tyr Leu Gly Asp Ala Arg Pro Tyr Met 180 185 190 GAC GTC ATG CTG GAT CGC ACG CCG GCC GGG ACT GTG GCC ATC GGC GGC 1122 Asp Val Met Leu Asp Arg Thr Pro Ala Gly Thr Val Ala Ile Gly Gly 195 200 205 ATG CAG AAG TGG GTG ATT CCG TGC AAC TGG AAG TTT GCC GCC GAG CAG 1170 Met Gln Lys Trp Val Ile Pro Cys Asn Trp Lys Phe Ala Ala Glu Gln 210 215 220 TTC TGC AGT GAC ATG TAC CAC GCC GGC ACC ATG TCG CAC CTG TCC GGC 1218 Phe Cys Ser Asp Met Tyr His Ala Gly Thr Met Ser His Leu Ser Gly 225 230 235 240 ATC CTG GCG GGC ATG CCG CCG GAA ATG GAC CTG TCG CAT GCA CAG GTG 1266 Ile Leu Ala Gly Met Pro Pro Glu Met Asp Leu Ser His Ala Gln Val 245 250 255 CCC ACC AAG GGC AAC CAG TTC CGG GCC GGC TGG GGC GGG CAC GGC TCG 1314 Pro Thr Lys Gly Asn Gln Phe Arg Ala Gly Trp Gly Gly His Gly Ser 260 265 270 GGC TGG TTC GTC GAC GAG CCG GGC ATG CTC ATG GCG GTG ATG GGG CCC 1362 Gly Trp Phe Val Asp Glu Pro Gly Met Leu Met Ala Val Met Gly Pro 275 280 285 AAG GTC ACC CAG TAC TGG ACC GAA GGT CCG GCT GCC GAC CTG GCA GAA 1410 Lys Val Thr Gln Tyr Trp Thr Glu Gly Pro Ala Ala Asp Leu Ala Glu 290 295 300 CAG CGA CTG GGC CAC ACC ATG CCG GTT CGA CGC ATG TTC GGC CAG CAC 1458 Gln Arg Leu Gly His Thr Met Pro Val Arg Arg Met Phe Gly Gln His 305 310 315 320 ATG ACG ATC TTC CCG ACC TGT TCA TTC CTG CCC GCC ATC AAC ACC ATC 1506 Met Thr Ile Phe Pro Thr Cys Ser Phe Leu Pro Ala Ile Asn Thr Ile 325 330 335 CGG ACC TGG CAC CCG CGT GGT CCC AAT GAA ATC GAG GTG TGG GCC TTC 1554 Arg Thr Trp His Pro Arg Gly Pro Asn Glu Ile Glu Val Trp Ala Phe 340 345 350 ACC CTG GTC GAT GCC GAC GCC CCG GCG GAG ATC AAG GAA GAA TAT CGC 1602 Thr Leu Val Asp Ala Asp Ala Pro Ala Glu Ile Lys Glu Glu Tyr Arg 355 360 365 CGG CAC AAC ATC CGC ACC TTC TCC GCA GGC GGC GTG TTT GAG CAG GAC 1650 Arg His Asn Ile Arg Thr Phe Ser Ala Gly Gly Val Phe Glu Gln Asp 370 375 380 GAT GGC GAG AAC TGG GTG GAG ATC CAG AAG GGG CTA CGT GGG TAC AAG 1698 Asp Gly Glu Asn Trp Val Glu Ile Gln Lys Gly Leu Arg Gly Tyr Lys 385 390 395 400 GCC AAG AGC CAG CCG CTC AAT GCC CAG ATG GGC CTG GGT CGG TGC AGA 1746 Ala Lys Ser Gln Pro Leu Asn Ala Gln Met Gly Leu Gly Arg Cys Arg 405 410 415 CCG GAT CAC CCT GAT TTT CCT GGC AAC GTC GGC 1779 Pro Asp His Pro Asp Phe Pro Gly Asn Val Gly 420 425 TAGCTCTACG CCGAAGAAGC GGCGCGGGGT ATGTATCACC ACTGGATGCG CATGATGTCC 1839 GAGCCCAGCT GGGCCACGCT CAAGCCCTGA TCAAGACGCA ATCGTTAGAT CTGTCAACCG 1899 GAAGAATTCA AC 1911 ATG GTG GGC TGG ACG TGC ATG TGC AGA CGG CGC GCC GAG GTT CCG TCC 1959 Met Val Gly Trp Thr Cys Met Cys Arg Arg Arg Ala Glu Val Pro Ser 1 5 10 15 CCT GAT ATT TAC TTG GAG ATA ACT ATT ATG ACA AAT CCA TCC CCG CAT 2007 Pro Asp Ile Tyr Leu Glu Ile Thr Ile Met Thr Asn Pro Ser Pro His 20 25 30 TTT TTC AAA ACA TTT GAA TGG CCA AGC AAG GCG GCT GGC CTT GAG TTG 2055 Phe Phe Lys Thr Phe Glu Trp Pro Ser Lys Ala Ala Gly Leu Glu Leu 35 40 45 CAG AAC GAG ATC GAG CAG TTC TAC TAC CGC GAA GCG CAG TTG CTT GAC 2103 Gln Asn Glu Ile Glu Gln Phe Tyr Tyr Arg Glu Ala Gln Leu Leu Asp 50 55 60 CAC CGG GCC TAC GAG GCC TGG TTT GCC CTG CTG GAC AAA GAT ATC CAC 2151 His Arg Ala Tyr Glu Ala Trp Phe Ala Leu Leu Asp Lys Asp Ile His 65 70 75 80 TAC TTC ATG CCG CTG CGC ACC AAT CGC ATG ATC CGG GAG GGC GAG CTG 2199 Tyr Phe Met Pro Leu Arg Thr Asn Arg Met Ile Arg Glu Gly Glu Leu 85 90 95 GAA TAT TCC GGC GAC CAG GAT ATT GCC CAT TTC GAT GAA ACC CAT GAA 2247 Glu Tyr Ser Gly Asp Gln Asp Ile Ala His Phe Asp Glu Thr His Glu 100 105 110 ACC ATG TAC GGG CGC ATC CGC AAG GTG ACC TCG GAC GTG GGC TGG GCG 2295 Thr Met Tyr Gly Arg Ile Arg Lys Val Thr Ser Asp Val Gly Trp Ala 115 120 125 GAG AAC CCG CCT TCC CGC ACG CGC CAC CTG GTC TCC AAC GTC ATC GTC 2343 Glu Asn Pro Pro Ser Arg Thr Arg His Leu Val Ser Asn Val Ile Val 130 135 140 AAG GAG ACG GCC ACG CCG GAT ACC TTC GAG GTC AAT TCC GCA TTC ATC 2391 Lys Glu Thr Ala Thr Pro Asp Thr Phe Glu Val Asn Ser Ala Phe Ile 145 150 155 160 CTG TAC CGC AAT CGG CTT GAG CGC CAG GTC GAC ATC TTC GCG GGC GAA 2439 Leu Tyr Arg Asn Arg Leu Glu Arg Gln Val Asp Ile Phe Ala Gly Glu 165 170 175 CGC CGG GAC GTG CTG CGC CGC GCC GAC AAC AAC CTT GGT TTC AGC ATC 2487 Arg Arg Asp Val Leu Arg Arg Ala Asp Asn Asn Leu Gly Phe Ser Ile 180 185 190 GCC AAG CGC ACC ATC CTG CTC GAC GCC AGT ACC TTG CTG TCG AAC AAC 2535 Ala Lys Arg Thr Ile Leu Leu Asp Ala Ser Thr Leu Leu Ser Asn Asn 195 200 205 CTG AGC ATG TTC TTC 2550 Leu Ser Met Phe Phe 210 TAGCCCAGCA CGCTGAACCG GCCTCAATGA GGATGCTGCC 2590 ATG AAA AAT GCA AGA CTG TTT TTG ATC GCC ATC GGC GTC TTC TAC ATC 2638 Met Lys Asn Ala Arg Leu Phe Leu Ile Ala Ile Gly Val Phe Tyr Ile 1 5 10 15 ATC AAC CTC ATT GGC ACG CTT CCC TTC AGC ACG TTG GGC TTG TTT GGC 2686 Ile Asn Leu Ile Gly Thr Leu Pro Phe Ser Thr Leu Gly Leu Phe Gly 20 25 30 AGG ATG TAT CCA GGC GTA GAA CTG CAC GTG GGT GCG CCG ATT TTC ACC 2734 Arg Met Tyr Pro Gly Val Glu Leu His Val Gly Ala Pro Ile Phe Thr 35 40 45 CTG CTG CAG GAT GCC TGG GCG GTG GTC GGT CTC CAG TTG GGC GCC ATC 2782 Leu Leu Gln Asp Ala Trp Ala Val Val Gly Leu Gln Leu Gly Ala Ile 50 55 60 GGG GCC GTC GCT TTG TGG GGC GCC CGC GAT CCG GGC CGT TAT CGG GCC 2830 Gly Ala Val Ala Leu Trp Gly Ala Arg Asp Pro Gly Arg Tyr Arg Ala 65 70 75 80 GTT ATT CCA GTG GTC ATC GCA ACG GAA GTG GTC GAT GGC CTC TGG GAT 2878 Val Ile Pro Val Val Ile Ala Thr Glu Val Val Asp Gly Leu Trp Asp 85 90 95 TTT TAC AGC ATC GTG TGG AGC CAC GAA GCC TTG TGG TTC GGG CTT GTC 2926 Phe Tyr Ser Ile Val Trp Ser His Glu Ala Leu Trp Phe Gly Leu Val 100 105 110 ACG CTG GTG ATC CAT GTG CTG TGG ATT GGC TGG GGC CTG CAT GCC TGG 2974 Thr Leu Val Ile His Val Leu Trp Ile Gly Trp Gly Leu His Ala Trp 115 120 125 CGT GCC TGG CGT CGA AAT CGC 2995 Arg Ala Trp Arg Arg Asn Arg 130 135 TGAGGACACT TTGAATTACT CTTCAGCCAC CAACAGTGAC TGTTCGCCCC AGGCGATTTA 3055 ACCCTTTTAA CTAATTACAA GAAGCGTT 3083 ATG AAA TTT ACC AGA GTT TGT GAT CGA AGA GAT GTG CCC GAA GGC GAA 3131 Met Lys Phe Thr Arg Val Cys Asp Arg Arg Asp Val Pro Glu Gly Glu 1 5 10 15 GCC CTG AAG GTC GAA AGT GGA GGC ACC TCC GTC GCG ATT TTC AAT GTG 3179 Ala Leu Lys Val Glu Ser Gly Gly Thr Ser Val Ala Ile Phe Asn Val 20 25 30 GAT GGC GAG CTG TTC GCA ACA CAG GAC CGC TGC ACC CAC GGC GAC TGG 3227 Asp Gly Glu Leu Phe Ala Thr Gln Asp Arg Cys Thr His Gly Asp Trp 35 40 45 TCC CTG TCC GAT GGC GGC TAT CTT GAA GGT GAC GTG GTG GAA TGC TCA 3275 Ser Leu Ser Asp Gly Gly Tyr Leu Glu Gly Asp Val Val Glu Cys Ser 50 55 60 CTG CAC ATG GGG AAG TTT TGC GTT CGC ACG GGC AAG GTC AAA TCA CCG 3323 Leu His Met Gly Lys Phe Cys Val Arg Thr Gly Lys Val Lys Ser Pro 65 70 75 80 CCG CCC TGT GAG GCA CTG AAG ATA TTT CCG ATC CGC ATC GAA GAC AAT 3371 Pro Pro Cys Glu Ala Leu Lys Ile Phe Pro Ile Arg Ile Glu Asp Asn 85 90 95 GAC GTG CTG GTC GAC TTC GAA GCC GGG TAT CTG GCG CC 3409 Asp Val Leu Val Asp Phe Glu Ala Gly Tyr Leu Ala Pro 100 105 ATG ATC GAC ACC ATC GCC ATC ATC GGC GCC GGC CTG GCC GTT CGA CGG 3457 Met Ile Asp Thr Ile Ala Ile Ile Gly Ala Gly Leu Ala Val Arg Arg 1 5 10 15 CTG CGC GCG CAC TGC CGC CAG GGA TAC GAG GGG CGC ATC CAC CTG CTC 3505 Leu Arg Ala His Cys Arg Gln Gly Tyr Glu Gly Arg Ile His Leu Leu 20 25 30 GGG GAT GAG TCG CAT CAG GCC TAT GAC CGG ACC ACG CTG TCC AAG ACG 3553 Gly Asp Glu Ser His Gln Ala Tyr Asp Arg Thr Thr Leu Ser Lys Thr 35 40 45 GTG CTG GCG GGC GAG CAG CCC GAG CCG CCT GCA ATC CTG GAC AGC GCC 3601 Val Leu Ala Gly Glu Gln Pro Glu Pro Pro Ala Ile Leu Asp Ser Ala 50 55 60 TGG TAC GCA TCG GCC CAT GTG GAT GTC CAG CTC GGG CGA CGG GTG AGT 3649 Trp Tyr Ala Ser Ala His Val Asp Val Gln Leu Gly Arg Arg Val Ser 65 70 75 80 TGC CTG GAT CTG GCC AAC CGC CAG ATT CAG TTT GAA TCG GGC GCC CCG 3697 Cys Leu Asp Leu Ala Asn Arg Gln Ile Gln Phe Glu Ser Gly Ala Pro 85 90 95 CTG GCC TAC GAC CGG CTG CTG CTG GCC ACC GGC GCG CGC GCC CGG CGC 3745 Leu Ala Tyr Asp Arg Leu Leu Leu Ala Thr Gly Ala Arg Ala Arg Arg 100 105 110 ATG GCG ATT CGG GGT GGC GAC CTG GCA GGC ATC CAT ACC TTG CGA GAC 3793 Met Ala Ile Arg Gly Gly Asp Leu Ala Gly Ile His Thr Leu Arg Asp 115 120 125 CTC GCC GAC AGC CAG GCG CTG CGG CAG GCG CTG CAA CCG GGC CAG TCG 3841 Leu Ala Asp Ser Gln Ala Leu Arg Gln Ala Leu Gln Pro Gly Gln Ser 130 135 140 CTG GTC ATC GTC GGC GGA GGC CTG ATC GGT TGC GAG GTG GCG ACC ACC 3889 Leu Val Ile Val Gly Gly Gly Leu Ile Gly Cys Glu Val Ala Thr Thr 145 150 155 160 GCC CGC AAG CTG AGT GTC CAT GTC ACG ATT CTG GAA GCC GGC GAC GAG 3937 Ala Arg Lys Leu Ser Val His Val Thr Ile Leu Glu Ala Gly Asp Glu 165 170 175 TTG CTG GTG CGC GTG CTG GGT CAC CGG ACC GGG GCA TGG TGT CGG GCC 3985 Leu Leu Val Arg Val Leu Gly His Arg Thr Gly Ala Trp Cys Arg Ala 180 185 190 GAA CTG GAA CGC ATG GGT GTC CGC GTG GAG CGC AAT GCA CAG GCC GCG 4033 Glu Leu Glu Arg Met Gly Val Arg Val Glu Arg Asn Ala Gln Ala Ala 195 200 205 CGC TTC GAA GGC CAG GGG CAG GTG CGC GCC GTG ATC TGC GCC GAC GGG 4081 Arg Phe Glu Gly Gln Gly Gln Val Arg Ala Val Ile Cys Ala Asp Gly 210 215 220 CGC CGG GTG CCC GCC GAT GTG GTC TTG GTC AGC ATT GGC GCC GAG CCG 4129 Arg Arg Val Pro Ala Asp Val Val Leu Val Ser Ile Gly Ala Glu Pro 225 230 235 240 GCG GAC GAG CTG GCC CGT GCC GCT GGC ATC GCC TGC GCG CGC GGC GTG 4177 Ala Asp Glu Leu Ala Arg Ala Ala Gly Ile Ala Cys Ala Arg Gly Val 245 250 255 CTG GTC GAC GCC ACC GGC GCC ACC TCG TGT CCA GAG GTG TTC GCC GCC 4225 Leu Val Asp Ala Thr Gly Ala Thr Ser Cys Pro Glu Val Phe Ala Ala 260 265 270 GGT GAC GTC GCC GCC TGG CCG CTG CGT CAA GGG GGC CAG CGC TCG CTG 4273 Gly Asp Val Ala Ala Trp Pro Leu Arg Gln Gly Gly Gln Arg Ser Leu 275 280 285 GAG ACC TAC CTG AAC AGC CAG ATG GAG GCC GAA ATC GCG GCC AGC GCC 4321 Glu Thr Tyr Leu Asn Ser Gln Met Glu Ala Glu Ile Ala Ala Ser Ala 290 295 300 ATG TTG AGT CAG CCC GTG CCG GCG CCC CAG GTG CCG ACC TCG TGG ACG 4369 Met Leu Ser Gln Pro Val Pro Ala Pro Gln Val Pro Thr Ser Trp Thr 305 310 315 320 GAG ATT GCA GGC CAC CGC ATC CAG ATG ATT GGC GAT GCC GAA GGG CCC 4417 Glu Ile Ala Gly His Arg Ile Gln Met Ile Gly Asp Ala Glu Gly Pro 325 330 335 GGC GAG ATC GTC GTA CGC GGC GAC GCC CAG AGC GGC CAG CCA ATC GTG 4465 Gly Glu Ile Val Val Arg Gly Asp Ala Gln Ser Gly Gln Pro Ile Val 340 345 350 TTG CTC AGG CTG CTT GAT GGC TGC GTC GAG GCC GCG ACG GCG ATC AAT 4513 Leu Leu Arg Leu Leu Asp Gly Cys Val Glu Ala Ala Thr Ala Ile Asn 355 360 365 GCC ACC AGG GAA TTT TCT GTG GCG ACC CGA CTG GTC GGC ACC CGG GTT 4561 Ala Thr Arg Glu Phe Ser Val Ala Thr Arg Leu Val Gly Thr Arg Val 370 375 380 TCT GTT TCC GCC GAG CAA CTG CAG GAC GTC GGC TCG AAC CTG CGG GAT 4609 Ser Val Ser Ala Glu Gln Leu Gln Asp Val Gly Ser Asn Leu Arg Asp 385 390 395 400 TTA CTC AAA GCC AAA CCG AAT 4630 Leu Leu Lys Ala Lys Pro Asn 405 TGATGCGCAT GACCGGCGAA TCGCTTTAAC AATAAAGGGG ATTGGGGATT GGAAAAATGA 4690 AACTGAAAGG TGAACGGGTA CTGTCACGGG G 4721[Sequence list] Sequence length: 7421 Sequence type: Nucleic acid Number of strands: Double strand Topology: Linear Sequence type: Genomic DNA Origin: Organism name: Shoot {monas erquimonosa} (Pseudomonas aeruginosa) Strain name: JI104 Sequence Features Symbol indicating feature: -10 signal Location: 479..484 Method determining feature: S Symbol indicating feature: -35 signal Location: 455..460 Method determining feature: S array CTCGAGAGCG AATGTACGCC AAAGCGTGCT GAATGGTGAC GCTGAATGGG AGGCGCGGAT 60 CGTCAGTTCG TTTCACCGAC TGTCATTGAT TGAAGAGCCC ACGATGCGGG ATCCGGCTCG 120 CTGGTTTAAT GAGTGGGAGC CAGTCAACCG CCGGTTTTCA CGAAGCTCTT ATCTCTGCCC 180 TGTTCGTCCG TCTGGATCCG GCGGTTCCTG TCCATCCTGT ATGTGCATAT GGAGCGCTAC 240 CGCCGATTGA CTGCTATGCA CAACCCGCCT ACCAGAAACG TACATGAGGA GCATCTAGCA 300 CTTCGCGACA GCCGCTCGCC GGAGATGCCG AGCGCTGTGC TGCGTTGATG GCGGAGCACA 360 TCGAATCATC AATTTCGGTG GTTCGGGAAT TCGGTTTGTT GAGGTGACGC CAACATCCCA 420 CGTGTTTGTT TTCGTCGTGA TGGATGCGGT CGGCATTTTT TC GCCCTACT AAGGGCATTT 480 CAAAGGAGAC GTTGAATC 498 ATG AGC TCA TCA ATC AAA GAA GTG CAG GGA GCC CCT GTG AAG TGG GTT 546 Met Ser Ser Ser Ile Lys Glu Val Gln Gly Ala Pro Val Lys Trp Val 1 5 10 15 ACC AAT TGG ACG CCG GCG ATC CGG GGG TTG GTC GAT CAG GAA AAA 594 Thr Asn Trp Thr Pro Glu Ala Ile Arg Gly Leu Val Asp Gln Glu Lys 20 25 30 GGG CTG CTT GAT CCA CGC ATC TAC GCC GAT CAG AGT CTT TAT GAG CTG 642 Gly Leu Leu Asp Pro Arg Ile Tyr Ala Asp Gln Ser Leu Tyr Glu Leu 35 40 45 GAG CTT GAG CGG GTT TTT GGT CGC TCT TGG CTG TTA CTT GGG CAC GAG 690 Glu Leu Glu Arg Val Phe Gly Arg Ser Trp Leu Leu Leu Gly His Glu 50 55 60 AGT CAT GTG CCT GAA ACC GGG GAC TTC CTG GCC ACT TAC ATG GGC GAA 738 Ser His Val Pro Glu Thr Gly Asp Phe Leu Ala Thr Tyr Met Gly Glu 65 70 75 80 GAT CCG GTG GTT ATG GTG CGA CAG AAA GAC AAG AGC ATC AAG GTG TTC 786 Asp Pro Val Val Met Val Arg Gln Lys Asp Lys Ser Ile Lys Val Phe 85 90 95 CTG AAC CAG TGC CGC GGC ATG CGT ATC TGC CGC TCG GAC GCC GGC AAC 834 Leu Asn Gln Cys Arg Gly Met Arg I le Cys Arg Ser Asp Ala Gly Asn 100 105 110 GCC AAG GCT TTC ACC TGC AGC TAT CAC GGC TGG GCC TAC GAC ATC GCC 882 Ala Lys Ala Phe Thr Cys Ser Tyr His Gly Trp Ala Tyr Asp Ile Ala 115 120 125 GGC AAG CTG GTG AAC GTG CCG TTC GAG AAG GAA GCC TTT TGC GAC AAG 930 Gly Lys Leu Val Asn Val Pro Phe Glu Lys Glu Ala Phe Cys Asp Lys 130 135 140 AAA GAA GGC GAC TGC GGC TTT GAC AAG GCC GAA TGG GGC CCG CTC CAG 978 Lys Glu Gly Asp Cys Gly Phe Asp Lys Ala Glu Trp Gly Pro Leu Gln 145 150 155 160 GCA CGC GTG GCA ACC TAC AAG GGC CTG GTC TTT GCC AAC TGG GAT GTG 1026 Ala Arg Val Ala Thr Tyr Lys Gly Leu Val Phe Ala Asn Trp Asp Val 165 170 175 CAG GCG CCA GAC CTG GAG ACC TAC CTC GGT GAC GCC CGC CCC TAT ATG 1074 Gln Ala Pro Asp Leu Glu Thr Tyr Leu Gly Asp Ala Arg Pro Tyr Met 180 185 190 GAC GTC ATG CTG GAT CGC ACG CCG GCC GGG ACT GTG GCC ATC GGC GGC 1122 Asp Val Met Leu Asp Arg Thr Pro Ala Gly Thr Val Ala Ile Gly Gly 195 200 205 ATG CAG AAG TGG GTG ATT CCG TGC AAC TGG AAG TTT GCC GCC GAG CAG 1170 Met Gln Lys Trp V al Ile Pro Cys Asn Trp Lys Phe Ala Ala Glu Gln 210 215 220 TTC TGC AGT GAC ATG TAC CAC GCC GGC ACC ATG TCG CAC CTG TCC GGC 1218 Phe Cys Ser Asp Met Tyr His Ala Gly Thr Met Ser His Leu Ser Gly 225 230 235 240 ATC CTG GCG GGC ATG CCG CCG GAA ATG GAC CTG TCG CAT GCA CAG GTG 1266 Ile Leu Ala Gly Met Pro Pro Glu Met Asp Leu Ser His Ala Gln Val 245 250 255 CCC ACC AAG GGC AAC CAG TTC CGG GCC GGC TGG GGC GGG CAC GGC TCG 1314 Pro Thr Lys Gly Asn Gln Phe Arg Ala Gly Trp Gly Gly His Gly Ser 260 265 270 GGC TGG TTC GTC GAC GAG CCG GGC ATG CTC ATG GCG GTG ATG GGG CCC 1362 Gly Trp Phe Val Asp Glu Pro Gly Met Leu Met Ala Val Met Gly Pro 275 280 285 AAG GTC ACC CAG TAC TGG ACC GAA GGT CCG GCT GCC GAC CTG GCA GAA 1410 Lys Val Thr Gln Tyr Trp Thr Glu Gly Pro Ala Ala Asp Leu Ala Glu 290 295 300 CAG CGA CTG GGC CAC ACC ATG CCG GTT CGA CGC ATG TTC GGC CAG CAC 1458 Gln Arg Leu Gly His Thr Met Pro Val Arg Arg Met Phe Gly Gln His 305 310 315 320 ATG ACG ATC TTC CCG ACC TGT TCA TTC CTG CCC GCC ATC AAC ACC AT C 1506 Met Thr Ile Phe Pro Thr Cys Ser Phe Leu Pro Ala Ile Asn Thr Ile 325 330 335 CGG ACC TGG CAC CCG CGT GGT CCC AAT GAA ATC GAG GTG TGG GCC TTC 1554 Arg Thr Trp His Pro Arg Gly Pro Asn Glu Ile Glu Val Trp Ala Phe 340 345 350 ACC CTG GTC GAT GCC GAC GCC CCG GCG GAG ATC AAG GAA GAA TAT CGC 1602 Thr Leu Val Asp Ala Asp Ala Pro Ala Glu Ile Lys Glu Glu Tyr Arg 355 360 365 CGG CAC AAC ATC CGC ACC TTC TCC GCA GGC GGC GTG TTT GAG CAG GAC 1650 Arg His Asn Ile Arg Thr Phe Ser Ala Gly Gly Val Phe Glu Gln Asp 370 375 380 GAT GGC GAG AAC TGG GTG GAG ATC CAG AAG GGG CTA CGT GGG TAC AAG 1698 Asp Gly Glu Asn Trp Val Glu Ile Gln Lys Gly Leu Arg Gly Tyr Lys 385 390 395 400 GCC AAG AGC CAG CCG CTC AAT GCC CAG ATG GGC CTG GGT CGG TGC AGA 1746 Ala Lys Ser Gln Pro Leu Asn Ala Gln Met Gly Leu Gly Arg Cys Arg 405 410 415 CCG GAT CAC CCT GAT TTT CCT GGC AAC GTC GGC 1779 Pro Asp His Pro Asp Phe Pro Gly Asn Val Gly 420 425 TAGCTCTACG CCGAAGAAGC GGCGCGGGGT ATGTATCACC ACTGGATGCG CATGATGTCC 1839 GAGCCCAGCT GGGCC ACGCT CAAGCCCTGA TCAAGACGCA ATCGTTAGAT CTGTCAACCG 1899 GAAGAATTCA AC 1911 ATG GTG GGC TGG ACG TGC ATG TGC AGA CGG CGC GCC GAG GTT CCG TCC 1959 Met Val Gly Trp Thr Cys Met Cys Arg Arg Arg Ala Glu Val Pro CT 1 ATT ATT TTG GAG ATA ACT ATT ATG ACA AAT CCA TCC CCG CAT 2007 Pro Asp Ile Tyr Leu Glu Ile Thr Ile Met Thr Asn Pro Ser Pro His 20 25 30 TTT TTC AAA ACA TTT GAA TGG CCA AGC AAG GCG GCT GGC CTT GAG TTG 2055 Phe Phe Lys Thr Phe Glu Trp Pro Ser Lys Ala Ala Gly Leu Glu Leu 35 40 45 CAG AAC GAG ATC GAG CAG TTC TAC TAC CGC GAA GCG CAG TTG CTT GAC 2103 Gln Asn Glu Ile Glu Gln Phe Tyr Tyr Arg Glu Ala Gln Leu Leu Asp 50 55 60 CAC CGG GCC TAC GAG GCC TGG TTT GCC CTG CTG GAC AAA GAT ATC CAC 2151 His Arg Ala Tyr Glu Ala Trp Phe Ala Leu Leu Asp Lys Asp Ile His 65 70 75 80 TAC TTC ATG CCG CTG CGC ACC AAT CGC ATG ATC CGG GAG GGC GAG CTG 2199 Tyr Phe Met Pro Leu Arg Thr Asn Arg Met Ile Arg Glu Gly Glu Leu 85 90 95 GAA TAT TCC GGC GAC CAG GAT ATT GCC CAT TTC GAT GAA ACC CAT GAA 2247 G lu Tyr Ser Gly Asp Gln Asp Ile Ala His Phe Asp Glu Thr His Glu 100 105 110 ACC ATG TAC GGG CGC ATC CGC AAG GTG ACC TCG GAC GTG GGC TGG GCG 2295 Thr Met Tyr Gly Arg Ile Arg Lys Val Thr Ser Asp Val Gly Trp Ala 115 120 125 GAG AAC CCG CCT TCC CGC ACG CGC CAC CTG GTC TCC AAC GTC ATC GTC 2343 Glu Asn Pro Pro Ser Arg Thr Arg His Leu Val Ser Asn Val Ile Val 130 135 140 AAG GAG ACG GCC ACG CCG GAT ACC TTC GAG GTC AAT TCC GCA TTC ATC 2391 Lys Glu Thr Ala Thr Pro Asp Thr Phe Glu Val Asn Ser Ala Phe Ile 145 150 155 160 CTG TAC CGC AAT CGG CTT GAG CGC CAG GTC GAC ATC TTC GCG GGC GAA 2439 Leu Tyr Arg Asn Arg Leu Glu Arg Gln Val Asp Ile Phe Ala Gly Glu 165 170 175 CGC CGG GAC GTG CTG CGC CGC GCC GAC AAC AAC CTT GGT TTC AGC ATC 2487 Arg Arg Asp Val Leu Arg Arg Ala Asp Asn Asn Leu Gly Phe Ser Ile 180 185 190 GCC AAG CGC ACC ATC CTG CTC GAC GCC AGT ACC TTG CTG TCG AAC AAC 2535 Ala Lys Arg Thr Ile Leu Leu Asp Ala Ser Thr Leu Leu Ser Asn Asn 195 200 205 CTG AGC ATG TTC TTC 2550 Leu Ser Met Phe Phe 210 TA GCCCAGCA CGCTGAACCG GCCTCAATGA GGATGCTGCC 2590 ATG AAA AAT GCA AGA CTG TTT TTG ATC GCC ATC GGC GTC TTC TAC ATC 2638 Met Lys Asn Ala Arg Leu Phe Leu Ile Ala Ile Gly Val Phe Tyr Ile 1 5 10 15 ATC AGC CTC CTCTC TTC AGC ACG TTG GGC TTG TTT GGC 2686 Ile Asn Leu Ile Gly Thr Leu Pro Phe Ser Thr Leu Gly Leu Phe Gly 20 25 30 AGG ATG TAT CCA GGC GTA GAA CTG CAC GTG GGT GCG CCG ATT TTC ACC 2734 Arg Met Tyr Pro Gly Val Glu Leu His Val Gly Ala Pro Ile Phe Thr 35 40 45 CTG CTG CAG GAT GCC TGG GCG GTG GTC GGT CTC CAG TTG GGC GCC ATC 2782 Leu Leu Gln Asp Ala Trp Ala Val Val Gly Leu Gln Leu Gly Ala Ile 50 55 60 GGG GCC GTC GCT TTG TGG GGC GCC CGC GAT CCG GGC CGT TAT CGG GCC 2830 Gly Ala Val Ala Leu Trp Gly Ala Arg Asp Pro Gly Arg Tyr Arg Ala 65 70 75 80 GTT ATT CCA GTG GTC ATC GCA ACG GAA GTG GTC GAT GGC CTC TGG GAT 2878 Val Ile Pro Val Val Ile Ala Thr Glu Val Val Asp Gly Leu Trp Asp 85 90 95 TTT TAC AGC ATC GTG TGG AGC CAC GAA GCC TTG TGG TTC GGG CTT GTC 2926 Phe Tyr Ser Ile Val Trp Ser His Glu Ala Leu Trp Phe Gly Leu Val 100 105 110 ACG CTG GTG ATC CAT GTG CTG TGG ATT GGC TGG GGC CTG CAT GCC TGG 2974 Thr Leu Val Ile His Val Leu Trp Ile Gly Trp Gly Leu His Ala Trp 115 120 125 CGT GCC TGG CGT CGA AAT CGC 2995 Arg Ala Trp Arg Arg Asn Arg 130 135 TGAGGACACT TTGAATTACT CTTCAGCCAC CAACAGTGAC TGTTCGCCCC AGGCGATTTA 3055 ACCCTTTTAA CTAATTACAA GAAGCGTT 3083 ATG AAA TTT ACC AGA GTT TGT GAT CGA AGA GAT GAT CGA AGA GAT GAT CGA AGA GAT GGA CGA GGA GAT GGA CGA AGA GAT GGA CGA GGA GAT CGA AGA GAT Asp Arg Arg Asp Val Pro Glu Gly Glu 1 5 10 15 GCC CTG AAG GTC GAA AGT GGA GGC ACC TCC GTC GCG ATT TTC AAT GTG 3179 Ala Leu Lys Val Glu Ser Gly Gly Thr Ser Val Ala Ile Phe Asn Val 20 25 30 GAT GGC GAG CTG TTC GCA ACA CAG GAC CGC TGC ACC CAC GGC GAC TGG 3227 Asp Gly Glu Leu Phe Ala Thr Gln Asp Arg Cys Thr His Gly Asp Trp 35 40 45 TCC CTG TCC GAT GGC GGC TAT CTT GAA GGT GAC GTG GTG GAA TGC TCA 3275 Ser Leu Ser Asp Gly Gly Tyr Leu Glu Gly Asp Val Val Glu Cys Ser 50 55 60 CTG CAC ATG GGG AAG TTT TGC GTT CGC ACG GGC AAG GTC AAA TCA C CG 3323 Leu His Met Gly Lys Phe Cys Val Arg Thr Gly Lys Val Lys Ser Pro 65 70 75 80 CCG CCC TGT GAG GCA CTG AAG ATA TTT CCG ATC CGC ATC GAA GAC AAT 3371 Pro Pro Cys Glu Ala Leu Lys Ile Phe Pro Ile Arg Ile Glu Asp Asn 85 90 95 GAC GTG CTG GTC GAC TTC GAA GCC GGG TAT CTG GCG CC 3409 Asp Val Leu Val Asp Phe Glu Ala Gly Tyr Leu Ala Pro 100 105 ATG ATC GAC ACC ATC GCC ATC ATC GGC GCC GGC CTG GCC GTT CGA CGG 3457 Met Ile Asp Thr Ile Ala Ile Ile Gly Ala Gly Leu Ala Val Arg Arg 1 5 10 15 CTG CGC GCG CAC TGC CGC CAG GGA TAC GAG GGG CGC ATC CAC CTG CTC 3505 Leu Arg Ala His Cys Arg Gln Gly Tyr Glu Gly Arg Ile His Leu Leu 20 25 30 GGG GAT GAG TCG CAT CAG GCC TAT GAC CGG ACC ACG CTG TCC AAG ACG 3553 Gly Asp Glu Ser His Gln Ala Tyr Asp Arg Thr Thr Leu Ser Lys Thr 35 40 45 GTG CTG GCG GGC GAG CAG CCC GAG CCG CCT GCA ATC CTG GAC AGC GCC 3601 Val Leu Ala Gly Glu Gln Pro Glu Pro Pro Ala Ile Leu Asp Ser Ala 50 55 60 TGG TAC GCA TCG GCC CAT GTG GAT GTC CAG CTC GGG CGA CGG GTG AGT 3649 Trp Tyr Ala Ser Ala His Val Asp Val Gln Leu Gly Arg Arg Val Ser 65 70 75 80 TGC CTG GAT CTG GCC AAC CGC CAG ATT CAG TTT GAA TCG GGC GCC CCG 3697 Cys Leu Asp Leu Ala Asn Arg Gln Ile Gln Phe Glu Ser Gly Ala Pro 85 90 95 CTG GCC TAC GAC CGG CTG CTG CTG GCC ACC GGC GCG CGC GCC CGG CGC 3745 Leu Ala Tyr Asp Arg Leu Leu Leu Ala Thr Gly Ala Arg Ala Arg Arg 100 105 110 ATG GCG ATT CGG GGT GGC GAC CTG GCA GGC ATC CAT ACC TTG CGA GAC 3793 Met Ala Ile Arg Gly Gly Asp Leu Ala Gly Ile His Thr Leu Arg Asp 115 120 125 CTC GCC GAC AGC CAG GCG CTG CGG CAG GCG CTG CAA CCG GGC CAG TCG 3841 Leu Ala Asp Ser Gln Ala Leu Arg Gln Ala Leu Gln Pro Gly Gln Ser 130 135 140 CTG GTC ATC GTC GGC GGA GGC CTG ATC GGT TGC GAG GTG GCG ACC ACC 3889 Leu Val Ile Val Gly Gly Gly Gly Leu Ile Gly Cys Glu Val Ala Thr Thr 145 150 155 160 GCC CGC AAG CTG AGT GTC CAT GTC ACG ATT CTG GAA GCC GGC GAC GAG 3937 Ala Arg Lys Leu Ser Val His Val Thr Ile Leu Glu Ala Gly Asp Glu 165 170 175 TTG CTG GTG CGC GTG CTG GGT CAC CGG ACC GGG GCA TGG TGT CGG GCC 3985 Leu Leu Val Arg Val Leu Gly His Arg Thr Gly Ala Trp Cys Arg Ala 180 185 190 GAA CTG GAA CGC ATG GGT GTC CGC GTG GAG CGC AAT GCA CAG GCC GCG 4033 Glu Leu Glu Arg Met Gly Val Arg Val Glu Arg Asn Ala Gln Ala Ala 195 200 205 CGC TTC GAA GGC CAG GGG CAG GTG CGC GCC GTG ATC TGC GCC GAC GGG 4081 Arg Phe Glu Gly Gln Gly Gln Val Arg Ala Val Ile Cys Ala Asp Gly 210 215 220 CGC CGG GTG CCC GCC GAT GTG GTC TTG GTC AGC ATT GGC GCC GAG CCG 4129 Arg Arg Val Pro Ala Asp Val Val Leu Val Ser Ile Gly Ala Glu Pro 225 230 235 240 GCG GAC GAG CTG GCC CGT GCC GCT GGC ATC GCC TGC GCG CGC GGC GTG 4177 Ala Asp Glu Leu Ala Arg Ala Ala Gly Ile Ala Cys Ala Arg Gly Val 245 250 255 CTG GTC GAC GCC ACC GGC GCC ACC TCG TGT CCA GAG GTG TTC GCC GCC 4225 Leu Val Asp Ala Thr Gly Ala Thr Ser Cys Pro Glu Val Phe Ala Ala 260 265 270 270 GGT GAC GTC GCC GCC TGG CCG CTG CGT CAA GGG GGC CAG CGC TCG CTG 4273 Gly Asp Val Ala Ala Trp Pro Leu Arg Gln Gly Gly Gln Arg Ser Leu 275 280 285 GAG ACC TAC CTG AAC AGC CAG ATG GAG GCC GAA ATC GCG G CC AGC GCC 4321 Glu Thr Tyr Leu Asn Ser Gln Met Glu Ala Glu Ile Ala Ala Ser Ala 290 295 300 ATG TTG AGT CAG CCC GTG CCG GCG CCC CAG GTG CCG ACC TCG TGG ACG 4369 Met Leu Ser Gln Pro Val Pro Ala Pro Gln Val Pro Thr Ser Trp Thr 305 310 315 320 GAG ATT GCA GGC CAC CGC ATC CAG ATG ATT GGC GAT GCC GAA GGG CCC 4417 Glu Ile Ala Gly His Arg Ile Gln Met Ile Gly Asp Ala Glu Gly Pro 325 330 335 GGC GAG ATC GTC GTA CGC GGC GAC GCC CAG AGC GGC CAG CCA ATC GTG 4465 Gly Glu Ile Val Val Arg Gly Asp Ala Gln Ser Gly Gln Pro Ile Val 340 345 350 TTG CTC AGG CTG CTT GAT GGC TGC GTC GAG GCC GCG ACG GCG ATC AAT 4513 Leu Leu Arg Leu Leu Asp Gly Cys Val Glu Ala Ala Thr Ala Ile Asn 355 360 365 GCC ACC AGG GAA TTT TCT GTG GCG ACC CGA CTG GTC GGC ACC CGG GTT 4561 Ala Thr Arg Glu Phe Ser Val Ala Thr Arg Leu Val Gly Thr Arg Val 370 375 380 TCT GTT TCC GCC GAG CAA CTG CAG GAC GTC GGC TCG AAC CTG CGG GAT 4609 Ser Val Ser Ala Glu Gln Leu Gln Asp Val Gly Ser Asn Leu Arg Asp 385 390 395 400 400 TTA CTC AAA GCC AAA CCG AAT 46 30 Leu Leu Lys Ala Lys Pro Asn 405 TGATGCGCAT GACCGGCGAA TCGCTTTAAC AATAAAGGGG ATTGGGGATT GGAAAAATGA 4690 AACTGAAAGG TGAACGGGTA CTGTCACGGG G 4721

【図面の簡単な説明】[Brief description of the drawings]

【図1】 NKKI1の制限酵素地図、及びNKKI1
に含まれるベンゼンジオキシゲナーゼ遺伝子(BD
O)、シスベンゼングリコールデヒドロゲナーゼ遺伝子
(cBDH)、及びカテコール 2,3−オキシゲナー
ゼ遺伝子(C23O)とベンゼンの代謝様式を示す図で
ある。
FIG. 1. Restriction map of NKKI1 and NKKI1
Benzene dioxygenase gene (BD
O), cisbenzene glycol dehydrogenase gene (cBDH), and catechol 2,3-oxygenase gene (C23O) and the metabolic pattern of benzene.

【図2】 NKKI1−1の制限酵素地図を示す図であ
る。
FIG. 2 is a diagram showing a restriction map of NKKI1-1.

【図3】 ベンゼンジオキシゲナーゼ遺伝子を含むNK
KI1からベンゼンジオキシゲナーゼ遺伝子を含む組み
換えプラスミドpBPT8−1を製造する工程を示す図
である。
FIG. 3 NK containing benzenedioxygenase gene
It is a figure which shows the process of producing the recombinant plasmid pBPT8-1 containing a benzenedioxygenase gene from KI1.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI C12R 1:19) (58)調査した分野(Int.Cl.7,DB名) C12N 15/00 - 15/90 C12N 1/00 - 1/38 C12N 9/00 - 9/99 C12P 1/00 - 41/00 BIOSIS(DIALOG) GenBank/EMBL/DDBJ(G ENETYX) WPI(DIALOG)──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 7 identification code FI C12R 1:19) (58) Investigated field (Int.Cl. 7 , DB name) C12N 15/00-15/90 C12N 1 / 00-1/38 C12N 9/00-9/99 C12P 1/00-41/00 BIOSIS (DIALOG) GenBank / EMBL / DDBJ (GENETYX) WPI (DIALOG)

Claims (17)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ベンゼンジオキシゲナーゼ遺伝子、シス
ベンゼングリコールデヒドロゲナーゼ遺伝子、及びカテ
コール 2,3−オキシゲナーゼ遺伝子を含む約7.2K
bのDNAであって、制限酵素の切断数がPstI:
6; EcoRI:2; SmaI:1; SalI:
5; BglII:1; BamHI:2; Sac
I:1; XhoI:1; XbaI:0; Hind
III:0; KpnI:0; SphI:6; 及び
ClaI:1であり、以下に示す制限酵素地図 【化1】 を有することを特徴とするDNA。
1. About 7.2K containing a benzene dioxygenase gene, a cis benzene glycol dehydrogenase gene, and a catechol 2,3-oxygenase gene.
b, wherein the number of cut restriction enzymes is PstI:
6; EcoRI: 2; SmaI: 1; SalI:
5; BglII: 1; BamHI: 2; Sac
XhoI: 1; XbaI: 0; Hind
III: 0; KpnI: 0; SphI: 6; and ClaI: 1, and the following restriction map: A DNA comprising:
【請求項2】 請求項1記載のDNAを有する組み換え
ベクターDNA。
2. A recombinant vector DNA having the DNA according to claim 1.
【請求項3】 プラスミドpXCY−Bpである請求項
2記載の組み換えベクターDNA。
3. The recombinant vector DNA according to claim 2, which is a plasmid pXCY-Bp.
【請求項4】 請求項2記載のベクターで形質転換され
ベンゼンジオキシゲナーゼ、シスベンゼングリコールデ
ヒドロゲナーゼ、及びカテコール 2,3−オキシゲナ
ーゼを産生する微生物。
4. A microorganism transformed with the vector according to claim 2 to produce benzenedioxygenase, cisbenzene glycol dehydrogenase, and catechol 2,3-oxygenase.
【請求項5】 大腸菌HB101/pXCY−Bpであ
る請求項4記載の微生物。
5. The microorganism according to claim 4, which is Escherichia coli HB101 / pXCY-Bp.
【請求項6】 ベンゼンジオキシゲナーゼ遺伝子を含む
約5.6KbのDNAであって、制限酵素の切断数がPs
tI:4; EcoRI:2; SmaI:1; Sa
lI:5; BglII:1; BamHI:2; S
acI:1;XhoI:1; XbaI:0; Hin
dIII:0; KpnI:0;SphI:6; 及び
ClaI:0であり、以下に示す制限酵素地図 【化2】 を有することを特徴とするDNA。
6. A DNA of about 5.6 Kb containing a benzenedioxygenase gene, wherein the number of restriction enzymes cut is Ps.
tI: 4; EcoRI: 2; SmaI: 1; Sa
11: BglII: 1; BamHI: 2; S
acI: 1; XhoI: 1; XbaI: 0; Hin
dIII: 0; KpnI: 0; SphI: 6; and ClaI: 0, and a restriction map shown below. A DNA comprising:
【請求項7】 請求項6記載のDNAを有する組み換え
ベクターDNA。
7. A recombinant vector DNA having the DNA according to claim 6.
【請求項8】 プラスミドpBPT8−1である請求項
7記載の組み換えベクターDNA。
8. The recombinant vector DNA according to claim 7, which is a plasmid pBPT8-1.
【請求項9】 請求項8記載のベクターで形質転換され
ベンゼンジオキシゲナーゼを産生する微生物。
9. A microorganism which is transformed with the vector according to claim 8 and produces benzenedioxygenase.
【請求項10】 大腸菌HB101/pBPT8−1で
ある請求項9記載の微生物。
10. The microorganism according to claim 9, which is Escherichia coli HB101 / pBPT8-1.
【請求項11】 以下に示す領域I、II、 III、IV、及
びVを含み、ベンゼンジオキシゲナーゼをコードするD
NA。 領域I ATG AGC TCA TCA ATC AAA GAA GTG CAG GGA GCC CCT GTG AAG TGG GTT ACC AAT TGG ACG CCG GAG GCG ATC CGG GGG TTG GTC GAT CAG GAA AAA GGG CTG CTT GAT CCA CGC ATC TAC GCC GAT CAG AGT CTT TAT GAG CTG GAG CTT GAG CGG GTT TTT GGT CGC TCT TGG CTG TTA CTT GGG CAC GAG AGT CAT GTG CCT GAA ACC GGG GAC TTC CTG GCC ACT TAC ATG GGC GAA GAT CCG GTG GTT ATG GTG CGA CAG AAA GAC AAG AGC ATC AAG GTG TTC CTG AAC CAG TGC CGC GGC ATG CGT ATC TGC CGC TCG GAC GCC GGC AAC GCC AAG GCT TTC ACC TGC AGC TAT CAC GGC TGG GCC TAC GAC ATC GCC GGC AAG CTG GTG AAC GTG CCG TTC GAG AAG GAA GCC TTT TGC GAC AAG AAA GAA GGC GAC TGC GGC TTT GAC AAG GCC GAA TGG GGC CCG CTC CAG GCA CGC GTG GCA ACC TAC AAG GGC CTG GTC TTT GCC AAC TGG GAT GTG CAG GCG CCA GAC CTG GAG ACC TAC CTC GGT GAC GCC CGC CCC TAT ATG GAC GTC ATG CTG GAT CGC ACG CCG GCC GGG ACT GTG GCC ATC GGC GGC ATG CAG AAG TGG GTG ATT CCG TGC AAC TGG AAG TTT GCC GCC GAG CAG TTC TGC AGT GAC ATG TAC CAC GCC GGC ACC ATG TCG CAC CTG TCC GGC ATC CTG GCG GGC ATG CCG CCG GAA ATG GAC CTG TCG CAT GCA CAG GTG CCC ACC AAG GGC AAC CAG TTC CGG GCC GGC TGG GGC GGG CAC GGC TCG GGC TGG TTC GTC GAC GAG CCG GGC ATG CTC ATG GCG GTG ATG GGG CCC AAG GTC ACC CAG TAC TGG ACC GAA GGT CCG GCT GCC GAC CTG GCA GAA CAG CGA CTG GGC CAC ACC ATG CCG GTT CGA CGC ATG TTC GGC CAG CAC ATG ACG ATC TTC CCG ACC TGT TCA TTC CTG CCC GCC ATC AAC ACC ATC CGG ACC TGG CAC CCG CGT GGT CCC AAT GAA ATC GAG GTG TGG GCC TTC ACC CTG GTC GAT GCC GAC GCC CCG GCG GAG ATC AAG GAA GAA TAT CGC CGG CAC AAC ATC CGC ACC TTC TCC GCA GGC GGC GTG TTT GAG CAG GAC GAT GGC GAG AAC TGG GTG GAG ATC CAG AAG GGG CTA CGT GGG TAC AAG GCC AAG AGC CAG CCG CTC AAT GCC CAG ATG GGC CTG GGT CGG TGC AGA CCG GAT CAC CCT GAT TTT CCT GGC AAC GTC GGC 領域II ATG GTG GGC TGG ACG TGC ATG TGC AGA CGG CGC GCC GAG GTT CCG TCC CCT GAT ATT TAC TTG GAG ATA ACT ATT ATG ACA AAT CCA TCC CCG CAT TTT TTC AAA ACA TTT GAA TGG CCA AGC AAG GCG GCT GGC CTT GAG TTG CAG AAC GAG ATC GAG CAG TTC TAC TAC CGC GAA GCG CAG TTG CTT GAC CAC CGG GCC TAC GAG GCC TGG TTT GCC CTG CTG GAC AAA GAT ATC CAC TAC TTC ATG CCG CTG CGC ACC AAT CGC ATG ATC CGG GAG GGC GAG CTG GAA TAT TCC GGC GAC CAG GAT ATT GCC CAT TTC GAT GAA ACC CAT GAA ACC ATG TAC GGG CGC ATC CGC AAG GTG ACC TCG GAC GTG GGC TGG GCG GAG AAC CCG CCT TCC CGC ACG CGC CAC CTG GTC TCC AAC GTC ATC GTC AAG GAG ACG GCC ACG CCG GAT ACC TTC GAG GTC AAT TCC GCA TTC ATC CTG TAC CGC AAT CGG CTT GAG CGC CAG GTC GAC ATC TTC GCG GGC GAA CGC CGG GAC GTG CTG CGC CGC GCC GAC AAC AAC CTT GGT TTC AGC ATC GCC AAG CGC ACC ATC CTG CTC GAC GCC AGT ACC TTG CTG TCG AAC AAC CTG AGC ATG TTC TTC 領域III ATG AAA AAT GCA AGA CTG TTT TTG ATC GCC ATC GGC GTC TTC TAC ATC ATC AAC CTC ATT GGC ACG CTT CCC TTC AGC ACG TTG GGC TTG TTT GGC AGG ATG TAT CCA GGC GTA GAA CTG CAC GTG GGT GCG CCG ATT TTC ACC CTG CTG CAG GAT GCC TGG GCG GTG GTC GGT CTC CAG TTG GGC GCC ATC GGG GCC GTC GCT TTG TGG GGC GCC CGC GAT CCG GGC CGT TAT CGG GCC GTT ATT CCA GTG GTC ATC GCA ACG GAA GTG GTC GAT GGC CTC TGG GAT TTT TAC AGC ATC GTG TGG AGC CAC GAA GCC TTG TGG TTC GGG CTT GTC ACG CTG GTG ATC CAT GTG CTG TGG ATT GGC TGG GGC CTG CAT GCC TGG CGT GCC TGG CGT CGA AAT CGC 領域IV ATG AAA TTT ACC AGA GTT TGT GAT CGA AGA GAT GTG CCC GAA GGC GAA GCC CTG AAG GTC GAA AGT GGA GGC ACC TCC GTC GCG ATT TTC AAT GTG GAT GGC GAG CTG TTC GCA ACA CAG GAC CGC TGC ACC CAC GGC GAC TGG TCC CTG TCC GAT GGC GGC TAT CTT GAA GGT GAC GTG GTG GAA TGC TCA CTG CAC ATG GGG AAG TTT TGC GTT CGC ACG GGC AAG GTC AAA TCA CCG CCG CCC TGT GAG GCA CTG AAG ATA TTT CCG ATC CGC ATC GAA GAC AAT GAC GTG CTG GTC GAC TTC GAA GCC GGG TAT CTG GCG CC 領域V ATG ATC GAC ACC ATC GCC ATC ATC GGC GCC GGC CTG GCC GTT CGA CGG CTG CGC GCG CAC TGC CGC CAG GGA TAC GAG GGG CGC ATC CAC CTG CTC GGG GAT GAG TCG CAT CAG GCC TAT GAC CGG ACC ACG CTG TCC AAG ACG GTG CTG GCG GGC GAG CAG CCC GAG CCG CCT GCA ATC CTG GAC AGC GCC TGG TAC GCA TCG GCC CAT GTG GAT GTC CAG CTC GGG CGA CGG GTG AGT TGC CTG GAT CTG GCC AAC CGC CAG ATT CAG TTT GAA TCG GGC GCC CCG CTG GCC TAC GAC CGG CTG CTG CTG GCC ACC GGC GCG CGC GCC CGG CGC ATG GCG ATT CGG GGT GGC GAC CTG GCA GGC ATC CAT ACC TTG CGA GAC CTC GCC GAC AGC CAG GCG CTG CGG CAG GCG CTG CAA CCG GGC CAG TCG CTG GTC ATC GTC GGC GGA GGC CTG ATC GGT TGC GAG GTG GCG ACC ACC GCC CGC AAG CTG AGT GTC CAT GTC ACG ATT CTG GAA GCC GGC GAC GAG TTG CTG GTG CGC GTG CTG GGT CAC CGG ACC GGG GCA TGG TGT CGG GCC GAA CTG GAA CGC ATG GGT GTC CGC GTG GAG CGC AAT GCA CAG GCC GCG CGC TTC GAA GGC CAG GGG CAG GTG CGC GCC GTG ATC TGC GCC GAC GGG CGC CGG GTG CCC GCC GAT GTG GTC TTG GTC AGC ATT GGC GCC GAG CCG GCG GAC GAG CTG GCC CGT GCC GCT GGC ATC GCC TGC GCG CGC GGC GTG CTG GTC GAC GCC ACC GGC GCC ACC TCG TGT CCA GAG GTG TTC GCC GCC GGT GAC GTC GCC GCC TGG CCG CTG CGT CAA GGG GGC CAG CGC TCG CTG GAG ACC TAC CTG AAC AGC CAG ATG GAG GCC GAA ATC GCG GCC AGC GCC ATG TTG AGT CAG CCC GTG CCG GCG CCC CAG GTG CCG ACC TCG TGG ACG GAG ATT GCA GGC CAC CGC ATC CAG ATG ATT GGC GAT GCC GAA GGG CCC GGC GAG ATC GTC GTA CGC GGC GAC GCC CAG AGC GGC CAG CCA ATC GTG TTG CTC AGG CTG CTT GAT GGC TGC GTC GAG GCC GCG ACG GCG ATC AAT GCC ACC AGG GAA TTT TCT GTG GCG ACC CGA CTG GTC GGC ACC CGG GTT TCT GTT TCC GCC GAG CAA CTG CAG GAC GTC GGC TCG AAC CTG CGG GAT TTA CTC AAA GCC AAA CCG AAT
11. A D which comprises the following regions I, II, III, IV and V and encodes benzenedioxygenase:
NA. Region I ATG AGC TCA TCA ATC AAA GAA GTG CAG GGA GCC CCT GTG AAG TGG GTT ACC AAT TGG ACG CCG GAG GCG ATC CGG GGG TTG GTC GAT CAG GAA AAA GGG CTG CTT GAT CCA CGC ATC TAC GCC GAT CAG AGT CTT TAT GAG CTG GAG CTT GAG CGG GTT TTT GGT CGC TCT TGG CTG TTA CTT GGG CAC GAG AGT CAT GTG CCT GAA ACC GGG GAC TTC CTG GCC ACT TAC ATG GGC GAA GAT CCG GTG GTT ATG GTG CGA CAG AAA GAC AAG AGC ATC AAG GTG TTC ATC CAG TGC CGC GGC ATG CGT ATC TGC CGC TCG GAC GCC GGC AAC GCC AAG GCT TTC ACC TGC AGC TAT CAC GGC TGG GCC TAC GAC ATC GCC GGC AAG CTG GTG AAC GTG CCG TTC GAG AAG GAA GCC TTT TGC GAC AAG AAA GAGC TGC GGC TTT GAC AAG GCC GAA TGG GGC CCG CTC CAG GCA CGC GTG GCA ACC TAC AAG GGC CTG GTC TTT GCC AAC TGG GAT GTG CAG GCG CCA GAC CTG GAG ACC TAC CTC GGT GAC GCC CGC CCC TAT ATG GAC GTC CTG CTG GAT ACG CCG GCC GGG ACT GTG GCC ATC GGC GGC ATG CAG AAG TGG GTG ATT CCG TGC AAC TGG AAG TTT GCC GCC GAG CAG TTC TGC AGT GAC ATG TAC CAC GCC GGC ACC ATG TCG CAC CTG TCC GGC ATC CTG GCG GGC ATG CCG CCG A ATG GAC CTG TCG CAT GCA CAG GTG CCC ACC AAG GGC AAC CAG TTC CGG GCC GGC TGG GGC GGG CAC GGC TCG GGC TGG TTC GTC GAC GAG CCG GGC ATG CTC ATG GCG GTG ATG GGG CCC AAG GTC ACC CAG TAC TGG ACC GAGA CCG GCT GCC GAC CTG GCA GAA CAG CGA CTG GGC CAC ACC ATG CCG GTT CGA CGC ATG TTC GGC CAG CAC ATG ACG ATC TTC CCG ACC TGT TCA TTC CTG CCC GCC ATC AAC ACC ATC CGG ACC TGG CAC CCG CGT GGT CTC AGA GAG GTG TGG GCC TTC ACC CTG GTC GAT GCC GAC GCC CCG GCG GAG ATC AAG GAA GAA TAT CGC CGG CAC AAC ATC CGC ACC TTC TCC GCA GGC GGC GTG TTT GAG CAG GAC GAT GGC GAG AAC TGG GTG GAG ATC CAG AGT GTA GGG TAC AAG GCC AAG AGC CAG CCG CTC AAT GCC CAG ATG GGC CTG GGT CGG TGC AGA CCG GAT CAC CCT GAT TTT CCT GGC AAC GTC GGC Area II ATG GTG GGC TGG ACG TGC ATG TGC AGA CGG CGC GCC GAG GTT CCG TCCCT ATT TAC TTG GAG ATA ACT ATT ATG ACA AAT CCA TCC CCG CAT TTT TTC AAA ACA TTT GAA TGG CCA AGC AAG GCG GCT GGC CTT GAG TTG CAG AAC GAG ATC GAG CAG TTC TAC TAC CGC GAA GCG CAG TTG CTT GAC CAC GGCC G AG GCC TGG TTT GCC CTG CTG GAC AAA GAT ATC CAC TAC TTC ATG CCG CTG CGC ACC AAT CGC ATG ATC CGG GAG GGC GAG CTG GAA TAT TCC GGC GAC CAG GAT ATT GCC CAT TTC GAT GAA ACC CAT GAA ACC ATG TAC GGG CTC ATC CGC AAG GTG ACC TCG GAC GTG GGC TGG GCG GAG AAC CCG CCT TCC CGC ACG CGC CAC CTG GTC TCC AAC GTC ATC GTC AAG GAG ACG GCC ACG CCG GAT ACC TTC GAG GTC AAT TCC GCA TTC ATC CTG TAC CGC AAT CGG CTT GGC CAG GTC GAC ATC TTC GCG GGC GAA CGC CGG GAC GTG CTG CGC CGC GCC GAC AAC AAC CTT GGT TTC AGC ATC GCC AAG CGC ACC ATC CTG CTC GAC GCC AGT ACC TTG CTG TCG AAC AAC CTG AGC ATG TTC TTC Area III ATG AAA GCA AGA CTG TTT TTG ATC GCC ATC GGC GTC TTC TAC ATC ATC AAC CTC ATT GGC ACG CTT CCC TTC AGC ACG TTG GGC TTG TTT GGC AGG ATG TAT CCA GGC GTA GAA CTG CAC GTG GGT GCG CCG ATT TTC ACC CTG CTG CAG GAT TGG GCG GTG GTC GGT CTC CAG TTG GGC GCC ATC GGG GCC GTC GCT TTG TGG GGC GCC CGC GAT CCG GGC CGT TAT CGG GCC GTT ATT CCA GTG GTC ATC GCA ACG GAA GTG GTC GAT GGC CTC TGG GAT TTT TAC AGC ATC GTG TGC CAC GAA GCC TTG TGG TTC GGG CTT GTC ACG CTG GTG ATC CAT GTG CTG TGG ATT GGC TGG GGC CTG CAT GCC TGG CGT GCC TGG CGT CGA AAT CGC region IV ATG AAA TTT ACC AGA GTT TGT GAT CGA AGA GAT GTG CCC GAAGA GCC CTG AAG GTC GAA AGT GGA GGC ACC TCC GTC GCG ATT TTC AAT GTG GAT GGC GAG CTG TTC GCA ACA CAG GAC CGC TGC ACC CAC GGC GAC TGG TCC CTG TCC GAT GGC GGC TAT CTT GAA GGT GAC GTG GTG GAA TGC TGC ATG GGG AAG TTT TGC GTT CGC ACG GGC AAG GTC AAA TCA CCG CCG CCC TGT GAG GCA CTG AAG ATA TTT CCG ATC CGC ATC GAA GAC AAT GAC GTG CTG GTC GAC TTC GAA GCC GGG TAT CTG GCG CC Area V ATG ATC GAC ACC ATC GCC ATC ATC GGC GCC GGC CTG GCC GTT CGA CGG CTG CGC GCG CAC TGC CGC CAG GGA TAC GAG GGG CGC ATC CAC CTG CTC GGG GAT GAG TCG CAT CAG GCC TAT GAC CGG ACC ACG CTG TCC AAG ACG GTG CTG GCG GGC GAG CAGC GAG CCG CCT GCA ATC CTG GAC AGC GCC TGG TAC GCA TCG GCC CAT GTG GAT GTC CAG CTC GGG CGA CGG GTG AGT TGC CTG GAT CTG GCC AAC CGC CAG ATT CAG TTT GAA TCG GGC GCC CCG CTG GCC TAC GAC CGG CTG CTG CTG CC ACC GGC GCG CGC GCC CGG CGC ATG GCG ATT CGG GGT GGC GAC CTG GCA GGC ATC CAT ACC TTG CGA GAC CTC GCC GAC AGC CAG GCG CTG CGG CAG GCG CTG CAA CCG GGC CAG TCG CTG GTC ATC GTC GGC GGA GGC CTC ATC TGC GAG GTG GCG ACC ACC GCC CGC AAG CTG AGT GTC CAT GTC ACG ATT CTG GAA GCC GGC GAC GAG TTG CTG GTG CGC GTG CTG GGT CAC CGG ACC GGG GCA TGG TGT CGG GCC GAA CTG GAA CGC ATG GGT GTC CGC GTG GAG CGC GCA CAG GCC GCG CGC TTC GAA GGC CAG GGG CAG GTG CGC GCC GTG ATC TGC GCC GAC GGG CGC CGG GTG CCC GCC GAT GTG GTC TTG GTC AGC ATT GGC GCC GAG CCG GCG GAC GAG CTG GCC CGT GCC GCT GGC ATC GCC TCG GGC GTG CTG GTC GAC GCC ACC GGC GCC ACC TCG TGT CCA GAG GTG TTC GCC GCC GGT GAC GTC GCC GCC TGG CCG CTG CGT CAA GGG GGC CAG CGC TCG CTG GAG ACC TAC CTG AAC AGC CAG ATG GAG GCC GAA ATC GCC GGC AGC ATG TTG AGT CAG CCC GTG CCG GCG CCC CAG GTG CCG ACC TCG TGG ACG GAG ATT GCA GGC CAC CGC ATC CAG ATG ATT GGC GAT GCC GAA GGG CCC GGC GAG ATC GTC GTA CGC GGC GAC GCC CAG AGC GGC CAG CCA ATC GTG A GG CTG CTT GAT GGC TGC GTC GAG GCC GCG ACG GCG ATC AAT GCC ACC AGG GAA TTT TCT GTG GCG ACC CGA CTG GTC GGC ACC CGG GTT TCT GTT TCC GCC GAG CAA CTG CAG GAC GTC GGC TCG AAC CTG CGG GAT TTA CTC AAA AAA CCG AAT
【請求項12】 下記のポリペプチドをコードするDN
A。 Met Ser Ser Ser Ile Lys Glu Val Gln Gly Ala Pro Val Lys Trp Val Thr Asn Trp Thr Pro Glu Ala Ile Arg Gly Leu Val Asp Gln Glu Lys Gly Leu Leu Asp Pro Arg Ile Tyr Ala Asp Gln Ser Leu Tyr Glu Leu Glu Leu Glu Arg Val Phe Gly Arg Ser Trp Leu Leu Leu Gly His Glu Ser His Val Pro Glu Thr Gly Asp Phe Leu Ala Thr Tyr Met Gly Glu Asp Pro Val Val Met Val Arg Gln Lys Asp Lys Ser Ile Lys Val Phe Leu Asn Gln Cys Arg Gly Met Arg Ile Cys Arg Ser Asp Ala Gly Asn Ala Lys Ala Phe Thr Cys Ser Tyr His Gly Trp Ala Tyr Asp Ile Ala Gly Lys Leu Val Asn Val Pro Phe Glu Lys Glu Ala Phe Cys Asp Lys Lys Glu Gly Asp Cys Gly Phe Asp Lys Ala Glu Trp Gly Pro Leu Gln Ala Arg Val Ala Thr Tyr Lys Gly Leu Val Phe Ala Asn Trp Asp Val Gln Ala Pro Asp Leu Glu Thr Tyr Leu Gly Asp Ala Arg Pro Tyr Met Asp Val Met Leu Asp Arg Thr Pro Ala Gly Thr Val Ala Ile Gly Gly Met Gln Lys Trp Val Ile Pro Cys Asn Trp Lys Phe Ala Ala Glu Gln Phe Cys Ser Asp Met Tyr His Ala Gly Thr Met Ser His Leu Ser Gly Ile Leu Ala Gly Met Pro Pro Glu Met Asp Leu Ser His Ala Gln Val Pro Thr Lys Gly Asn Gln Phe Arg Ala Gly Trp Gly Gly His Gly Ser Gly Trp Phe Val Asp Glu Pro Gly Met Leu Met Ala Val Met Gly Pro Lys Val Thr Gln Tyr Trp Thr Glu Gly Pro Ala Ala Asp Leu Ala Glu Gln Arg Leu Gly His Thr Met Pro Val Arg Arg Met Phe Gly Gln His Met Thr Ile Phe Pro Thr Cys Ser Phe Leu Pro Ala Ile Asn Thr Ile Arg Thr Trp His Pro Arg Gly Pro Asn Glu Ile Glu Val Trp Ala Phe Thr Leu Val Asp Ala Asp Ala Pro Ala Glu Ile Lys Glu Glu Tyr Arg Arg His Asn Ile Arg Thr Phe Ser Ala Gly Gly Val Phe Glu Gln Asp Asp Gly Glu Asn Trp Val Glu Ile Gln Lys Gly Leu Arg Gly Tyr Lys Ala Lys Ser Gln Pro Leu Asn Ala Gln Met Gly Leu Gly Arg Cys Arg Pro Asp His Pro Asp Phe Pro Gly Asn Val Gly
12. A DN encoding the following polypeptide:
A. Met Ser Ser Ser Ile Lys Glu Val Gln Gly Ala Pro Val Lys Trp Val Thr Asn Trp Thr Pro Glu Ala Ile Arg Gly Leu Val Asp Gln Glu Lys Gly Leu Leu Asp Pro Arg Ile Tyr Ala Asp Gln Ser Leu Tyr Glu Leu Glu Leu Glu Arg Val Phe Gly Arg Ser Trp Leu Leu Leu Gly His Glu Ser His Val Pro Glu Thr Gly Asp Phe Leu Ala Thr Tyr Met Gly Glu Asp Pro Val Val Met Val Arg Gln Lys Asp Lys Ser Ile Lys Val Phe Leu Asn Gln Cys Arg Gly Met Arg Ile Cys Arg Ser Asp Ala Gly Asn Ala Lys Ala Phe Thr Cys Ser Tyr His Gly Trp Ala Tyr Asp Ile Ala Gly Lys Leu Val Asn Val Pro Phe Glu Lys Glu Ala Phe Cys Asp Lys Lys Glu Gly Asp Cys Gly Phe Asp Lys Ala Glu Trp Gly Pro Leu Gln Ala Arg Val Ala Thr Tyr Lys Gly Leu Val Phe Ala Asn Trp Asp Val Gln Ala Pro Asp Leu Glu Thr Tyr Leu Gly Asp Ala Arg Pro Tyr Met Asp Val Met Leu Asp Arg Thr Pro Ala Gly Thr Val Ala Ile Gly Gly Met Gln Lys Trp Val Ile Pro Cys Asn Trp Lys Phe Ala Ala Glu Gln Phe Cys Ser Asp Met Tyr His Ala Gly Thr Met Ser His Leu Ser Gly Ile Leu Ala Gly Met Pro Pro Glu Met Asp Leu Ser His Ala Gln Val Pro Thr Lys Gly Asn Gln Phe Arg Ala Gly Trp Gly Gly His Gly Ser Gly Trp Phe Val Asp Glu Pro Gly Met Leu Met Ala Val Met Gly Pro Lys Val Thr Gln Tyr Trp Thr Glu Gly Pro Ala Ala Asp Leu Ala Glu Gln Arg Leu Gly His Thr Met Pro Val Arg Arg Met Phe Gly Gln His Met Thr Ile Phe Pro Thr Cys Ser Phe Leu Pro Ala Ile Asn Thr Ile Arg Thr Trp His Pro Arg Gly Pro Asn Glu Ile Glu Val Trp Ala Phe Thr Leu Val Asp Ala Asp Ala Pro Ala Glu Ile Lys Glu Glu Tyr Arg Arg His Asn Ile Arg Thr Phe Ser Ala Gly Gly Val Phe Glu Gln Asp Asp Gly Glu Asn Trp Val Glu Ile Gln Lys Gly Leu Arg Gly Tyr Lys Ala Lys Ser Gln Pro Leu Asn Ala Gln Met Gly Leu Gly Arg Cys Arg Pro Asp His Pro Asp Phe Pro Gly Asn Val Gly
【請求項13】 下記のポリペプチドをコードするDN
A。 Met Val Gly Trp Thr Cys Met Cys Arg Arg Arg Ala Glu Val Pro Ser Pro Asp Ile Tyr Leu Glu Ile Thr Ile Met Thr Asn Pro Ser Pro His Phe Phe Lys Thr Phe Glu Trp Pro Ser Lys Ala Ala Gly Leu Glu Leu Gln Asn Glu Ile Glu Gln Phe Tyr Tyr Arg Glu Ala Gln Leu Leu Asp His Arg Ala Tyr Glu Ala Trp Phe Ala Leu Leu Asp Lys Asp Ile His Tyr Phe Met Pro Leu Arg Thr Asn Arg Met Ile Arg Glu Gly Glu Leu Glu Tyr Ser Gly Asp Gln Asp Ile Ala His Phe Asp Glu Thr His Glu Thr Met Tyr Gly Arg Ile Arg Lys Val Thr Ser Asp Val Gly Trp Ala Glu Asn Pro Pro Ser Arg Thr Arg His Leu Val Ser Asn Val Ile Val Lys Glu Thr Ala Thr Pro Asp Thr Phe Glu Val Asn Ser Ala Phe Ile Leu Tyr Arg Asn Arg Leu Glu Arg Gln Val Asp Ile Phe Ala Gly Glu Arg Arg Asp Val Leu Arg Arg Ala Asp Asn Asn Leu Gly Phe Ser Ile Ala Lys Arg Thr Ile Leu Leu Asp Ala Ser Thr Leu Leu Ser Asn Asn Leu Ser Met Phe Phe
13. A DN encoding the following polypeptide:
A. Met Val Gly Trp Thr Cys Met Cys Arg Arg Arg Ala Glu Val Pro Ser Pro Asp Ile Tyr Leu Glu Ile Thr Ile Met Thr Asn Pro Ser Pro His Phe Phe Lys Thr Phe Glu Trp Pro Ser Lys Ala Ala Gly Leu Glu Leu Gln Asn Glu Ile Glu Gln Phe Tyr Tyr Arg Glu Ala Gln Leu Leu Asp His Arg Ala Tyr Glu Ala Trp Phe Ala Leu Leu Asp Lys Asp Ile His Tyr Phe Met Pro Leu Arg Thr Asn Arg Met Ile Arg Glu Gly Glu Leu Glu Tyr Ser Gly Asp Gln Asp Ile Ala His Phe Asp Glu Thr His Glu Thr Met Tyr Gly Arg Ile Arg Lys Val Thr Ser Asp Val Gly Trp Ala Glu Asn Pro Pro Ser Arg Thr Arg His Leu Val Ser Asn Val Ile Val Lys Glu Thr Ala Thr Pro Asp Thr Phe Glu Val Asn Ser Ala Phe Ile Leu Tyr Arg Asn Arg Leu Glu Arg Gln Val Asp Ile Phe Ala Gly Glu Arg Arg Asp Val Leu Arg Arg Ala Asp Asn Asn Leu Gly Phe Ser Ile Ala Lys Arg Thr Ile Leu Leu Asp Ala Ser Thr Leu Leu Ser Asn Asn Leu Ser Met Phe Phe
【請求項14】 下記のポリペプチドをコードするDN
A。 Met Lys Asn Ala Arg Leu Phe Leu Ile Ala Ile Gly Val Phe Tyr Ile Ile Asn Leu Ile Gly Thr Leu Pro Phe Ser Thr Leu Gly Leu Phe Gly Arg Met Tyr Pro Gly Val Glu Leu His Val Gly Ala Pro Ile Phe Thr Leu Leu Gln Asp Ala Trp Ala Val Val Gly Leu Gln Leu Gly Ala Ile Gly Ala Val Ala Leu Trp Gly Ala Arg Asp Pro Gly Arg Tyr Arg Ala Val Ile Pro Val Val Ile Ala Thr Glu Val Val Asp Gly Leu Trp Asp Phe Tyr Ser Ile Val Trp Ser His Glu Ala Leu Trp Phe Gly Leu Val Thr Leu Val Ile His Val Leu Trp Ile Gly Trp Gly Leu His Ala Trp Arg Ala Trp Arg Arg Asn Arg
14. A DN encoding the following polypeptide:
A. Met Lys Asn Ala Arg Leu Phe Leu Ile Ala Ile Gly Val Phe Tyr Ile Ile Asn Leu Ile Gly Thr Leu Pro Phe Ser Thr Leu Gly Leu Phe Gly Arg Met Tyr Pro Gly Val Glu Leu His Val Gly Ala Pro Ile Phe Thr Leu Leu Gln Asp Ala Trp Ala Val Val Gly Leu Gln Leu Gly Ala Ile Gly Ala Val Ala Leu Trp Gly Ala Arg Asp Pro Gly Arg Tyr Arg Ala Val Ile Pro Val Val Ile Ala Thr Glu Val Val Asp Gly Leu Trp Asp Phe Tyr Ser Ile Val Trp Ser His Glu Ala Leu Trp Phe Gly Leu Val Thr Leu Val Ile His Val Leu Trp Ile Gly Trp Gly Leu His Ala Trp Arg Ala Trp Arg Arg Asn Arg
【請求項15】 下記のポリペプチドをコードするDN
A。 Met Lys Phe Thr Arg Val Cys Asp Arg Arg Asp Val Pro Glu Gly Glu Ala Leu Lys Val Glu Ser Gly Gly Thr Ser Val Ala Ile Phe Asn Val Asp Gly Glu Leu Phe Ala Thr Gln Asp Arg Cys Thr His Gly Asp Trp Ser Leu Ser Asp Gly Gly Tyr Leu Glu Gly Asp Val Val Glu Cys Ser Leu His Met Gly Lys Phe Cys Val Arg Thr Gly Lys Val Lys Ser Pro Pro Pro Cys Glu Ala Leu Lys Ile Phe Pro Ile Arg Ile Glu Asp Asn Asp Val Leu Val Asp Phe Glu Ala Gly Tyr Leu Ala Pro
15. A DN encoding the following polypeptide:
A. Met Lys Phe Thr Arg Val Cys Asp Arg Arg Asp Val Pro Glu Gly Glu Ala Leu Lys Val Glu Ser Gly Gly Thr Ser Val Ala Ile Phe Asn Val Asp Gly Glu Leu Phe Ala Thr Gln Asp Arg Cys Thr His Gly Asp Trp Ser Leu Ser Asp Gly Gly Tyr Leu Glu Gly Asp Val Val Glu Cys Ser Leu His Met Gly Lys Phe Cys Val Arg Thr Gly Lys Val Lys Ser Pro Pro Pro Cys Glu Ala Leu Lys Ile Phe Pro Ile Arg Ile Glu Asp Asn Asp Val Leu Val Asp Phe Glu Ala Gly Tyr Leu Ala Pro
【請求項16】 下記のポリペプチドをコードするD
NA。 Met Ile Asp Thr Ile Ala Ile Ile Gly Ala Gly Leu Ala Val Arg Arg Leu Arg Ala His Cys Arg Gln Gly Tyr Glu Gly Arg Ile His Leu Leu Gly Asp Glu Ser His Gln Ala Tyr Asp Arg Thr Thr Leu Ser Lys Thr Val Leu Ala Gly Glu Gln Pro Glu Pro Pro Ala Ile Leu Asp Ser Ala Trp Tyr Ala Ser Ala His Val Asp Val Gln Leu Gly Arg Arg Val Ser Cys Leu Asp Leu Ala Asn Arg Gln Ile Gln Phe Glu Ser Gly Ala Pro Leu Ala Tyr Asp Arg Leu Leu Leu Ala Thr Gly Ala Arg Ala Arg Arg Met Ala Ile Arg Gly Gly Asp Leu Ala Gly Ile His Thr Leu Arg Asp Leu Ala Asp Ser Gln Ala Leu Arg Gln Ala Leu Gln Pro Gly Gln Ser Leu Val Ile Val Gly Gly Gly Leu Ile Gly Cys Glu Val Ala Thr Thr Ala Arg Lys Leu Ser Val His Val Thr Ile Leu Glu Ala Gly Asp Glu Leu Leu Val Arg Val Leu Gly His Arg Thr Gly Ala Trp Cys Arg Ala Glu Leu Glu Arg Met Gly Val Arg Val Glu Arg Asn Ala Gln Ala Ala Arg Phe Glu Gly Gln Gly Gln Val Arg Ala Val Ile Cys Ala Asp Gly Arg Arg Val Pro Ala Asp Val Val Leu Val Ser Ile Gly Ala Glu Pro Ala Asp Glu Leu Ala Arg Ala Ala Gly Ile Ala Cys Ala Arg Gly Val Leu Val Asp Ala Thr Gly Ala Thr Ser Cys Pro Glu Val Phe Ala Ala Gly Asp Val Ala Ala Trp Pro Leu Arg Gln Gly Gly Gln Arg Ser Leu Glu Thr Tyr Leu Asn Ser Gln Met Glu Ala Glu Ile Ala Ala Ser Ala Met Leu Ser Gln Pro Val Pro Ala Pro Gln Val Pro Thr Ser Trp Thr Glu Ile Ala Gly His Arg Ile Gln Met Ile Gly Asp Ala Glu Gly Pro Gly Glu Ile Val Val Arg Gly Asp Ala Gln Ser Gly Gln Pro Ile Val Leu Leu Arg Leu Leu Asp Gly Cys Val Glu Ala Ala Thr Ala Ile Asn Ala Thr Arg Glu Phe Ser Val Ala Thr Arg Leu Val Gly Thr Arg Val Ser Val Ser Ala Glu Gln Leu Gln Asp Val Gly Ser Asn Leu Arg Asp Leu Leu Lys Ala Lys Pro Asn
16. D encoding the following polypeptide:
NA. Met Ile Asp Thr Ile Ala Ile Ile Gly Ala Gly Leu Ala Val Arg Arg Leu Arg Ala His Cys Arg Gln Gly Tyr Glu Gly Arg Ile His Leu Leu Gly Asp Glu Ser His Gln Ala Tyr Asp Arg Thr Thr Leu Ser Lys Thr Val Leu Ala Gly Glu Gln Pro Glu Pro Pro Ala Ile Leu Asp Ser Ala Trp Tyr Ala Ser Ala His Val Asp Val Gln Leu Gly Arg Arg Val Ser Cys Leu Asp Leu Ala Asn Arg Gln Ile Gln Phe Glu Ser Gly Ala Pro Leu Ala Tyr Asp Arg Leu Leu Leu Ala Thr Gly Ala Arg Ala Arg Arg Met Ala Ile Arg Gly Gly Asp Leu Ala Gly Ile His Thr Leu Arg Asp Leu Ala Asp Ser Gln Ala Leu Arg Gln Ala Leu Gln Pro Gly Gln Ser Leu Val Ile Val Gly Gly Gly Leu Ile Gly Cys Glu Val Ala Thr Thr Ala Arg Lys Leu Ser Val His Val Thr Ile Leu Glu Ala Gly Asp Glu Leu Leu Val Arg Val Leu Gly His Arg Thr Gly Ala Trp Cys Arg Ala Glu Leu Glu Arg Met Gly Val Arg Val Glu Arg Asn Ala Gln Ala Ala Arg Phe Glu Gly Gln Gly Gln Val Arg Ala Val Ile Cys Ala Asp Gly Arg Arg Val Pro Ala Asp Val Val Leu Val Ser Ile Gly Ala Glu Pro Ala Asp Glu Leu Ala Arg Ala Ala Gly Ile Ala Cys Ala Arg Gly Val Leu Val Asp Ala Thr Gly Ala Thr Ser Cys Pro Glu Val Phe Ala Ala Gly Asp Val Ala Ala Trp Pro Leu Arg Gln Gly Gly Gln Arg Ser Leu Glu Thr Tyr Leu Asn Ser Gln Met Glu Ala Glu Ile Ala Ala Ser Ala Met Leu Ser Gln Pro Val Pro Ala Pro Gln Val Pro Thr Ser Trp Thr Glu Ile Ala Gly His Arg Ile Gln Met Ile Gly Asp Ala Glu Gly Pro Gly Glu Ile Val Val Arg Gly Asp Ala Gln Ser Gly Gln Pro Ile Val Leu Leu Arg Leu Leu Asp Gly Cys Val Glu Ala Ala Thr Ala Ile Asn Ala Thr Arg Glu Phe Ser Val Ala Thr Arg Leu Val Gly Thr Arg Val Ser Val Ser Ala Glu Gln Leu Gln Asp Val Gly Ser Asn Leu Arg Asp Leu Leu Lys Ala Lys Pro Asn
【請求項17】 下記のポリペプチドI、II、 III、I
V、及びVを含むベンゼンジオキシゲナーゼ。 ポリペプチドI Met Ser Ser Ser Ile Lys Glu Val Gln Gly Ala Pro Val Lys Trp Val Thr Asn Trp Thr Pro Glu Ala Ile Arg Gly Leu Val Asp Gln Glu Lys Gly Leu Leu Asp Pro Arg Ile Tyr Ala Asp Gln Ser Leu Tyr Glu Leu Glu Leu Glu Arg Val Phe Gly Arg Ser Trp Leu Leu Leu Gly His Glu Ser His Val Pro Glu Thr Gly Asp Phe Leu Ala Thr Tyr Met Gly Glu Asp Pro Val Val Met Val Arg Gln Lys Asp Lys Ser Ile Lys Val Phe Leu Asn Gln Cys Arg Gly Met Arg Ile Cys Arg Ser Asp Ala Gly Asn Ala Lys Ala Phe Thr Cys Ser Tyr His Gly Trp Ala Tyr Asp Ile Ala Gly Lys Leu Val Asn Val Pro Phe Glu Lys Glu Ala Phe Cys Asp Lys Lys Glu Gly Asp Cys Gly Phe Asp Lys Ala Glu Trp Gly Pro Leu Gln Ala Arg Val Ala Thr Tyr Lys Gly Leu Val Phe Ala Asn Trp Asp Val Gln Ala Pro Asp Leu Glu Thr Tyr Leu Gly Asp Ala Arg Pro Tyr Met Asp Val Met Leu Asp Arg Thr Pro Ala Gly Thr Val Ala Ile Gly Gly Met Gln Lys Trp Val Ile Pro Cys Asn Trp Lys Phe Ala Ala Glu Gln Phe Cys Ser Asp Met Tyr His Ala Gly Thr Met Ser His Leu Ser Gly Ile Leu Ala Gly Met Pro Pro Glu Met Asp Leu Ser His Ala Gln Val Pro Thr Lys Gly Asn Gln Phe Arg Ala Gly Trp Gly Gly His Gly Ser Gly Trp Phe Val Asp Glu Pro Gly Met Leu Met Ala Val Met Gly Pro Lys Val Thr Gln Tyr Trp Thr Glu Gly Pro Ala Ala Asp Leu Ala Glu Gln Arg Leu Gly His Thr Met Pro Val Arg Arg Met Phe Gly Gln His Met Thr Ile Phe Pro Thr Cys Ser Phe Leu Pro Ala Ile Asn Thr Ile Arg Thr Trp His Pro Arg Gly Pro Asn Glu Ile Glu Val Trp Ala Phe Thr Leu Val Asp Ala Asp Ala Pro Ala Glu Ile Lys Glu Glu Tyr Arg Arg His Asn Ile Arg Thr Phe Ser Ala Gly Gly Val Phe Glu Gln Asp Asp Gly Glu Asn Trp Val Glu Ile Gln Lys Gly Leu Arg Gly Tyr Lys Ala Lys Ser Gln Pro Leu Asn Ala Gln Met Gly Leu Gly Arg Cys Arg Pro Asp His Pro Asp Phe Pro Gly Asn Val Gly ポリペプチドII Met Val Gly Trp Thr Cys Met Cys Arg Arg Arg Ala Glu Val Pro Ser Pro Asp Ile Tyr Leu Glu Ile Thr Ile Met Thr Asn Pro Ser Pro His Phe Phe Lys Thr Phe Glu Trp Pro Ser Lys Ala Ala Gly Leu Glu Leu Gln Asn Glu Ile Glu Gln Phe Tyr Tyr Arg Glu Ala Gln Leu Leu Asp His Arg Ala Tyr Glu Ala Trp Phe Ala Leu Leu Asp Lys Asp Ile His Tyr Phe Met Pro Leu Arg Thr Asn Arg Met Ile Arg Glu Gly Glu Leu Glu Tyr Ser Gly Asp Gln Asp Ile Ala His Phe Asp Glu Thr His Glu Thr Met Tyr Gly Arg Ile Arg Lys Val Thr Ser Asp Val Gly Trp Ala Glu Asn Pro Pro Ser Arg Thr Arg His Leu Val Ser Asn Val Ile Val Lys Glu Thr Ala Thr Pro Asp Thr Phe Glu Val Asn Ser Ala Phe Ile Leu Tyr Arg Asn Arg Leu Glu Arg Gln Val Asp Ile Phe Ala Gly Glu Arg Arg Asp Val Leu Arg Arg Ala Asp Asn Asn Leu Gly Phe Ser Ile Ala Lys Arg Thr Ile Leu Leu Asp Ala Ser Thr Leu Leu Ser Asn Asn Leu Ser Met Phe Phe ポリペプチドIII Met Lys Asn Ala Arg Leu Phe Leu Ile Ala Ile Gly Val Phe Tyr Ile Ile Asn Leu Ile Gly Thr Leu Pro Phe Ser Thr Leu Gly Leu Phe Gly Arg Met Tyr Pro Gly Val Glu Leu His Val Gly Ala Pro Ile Phe Thr Leu Leu Gln Asp Ala Trp Ala Val Val Gly Leu Gln Leu Gly Ala Ile Gly Ala Val Ala Leu Trp Gly Ala Arg Asp Pro Gly Arg Tyr Arg Ala Val Ile Pro Val Val Ile Ala Thr Glu Val Val Asp Gly Leu Trp Asp Phe Tyr Ser Ile Val Trp Ser His Glu Ala Leu Trp Phe Gly Leu Val Thr Leu Val Ile His Val Leu Trp Ile Gly Trp Gly Leu His Ala Trp Arg Ala Trp Arg Arg Asn Arg ポリペプチドIV Met Lys Phe Thr Arg Val Cys Asp Arg Arg Asp Val Pro Glu Gly Glu Ala Leu Lys Val Glu Ser Gly Gly Thr Ser Val Ala Ile Phe Asn Val Asp Gly Glu Leu Phe Ala Thr Gln Asp Arg Cys Thr His Gly Asp Trp Ser Leu Ser Asp Gly Gly Tyr Leu Glu Gly Asp Val Val Glu Cys Ser Leu His Met Gly Lys Phe Cys Val Arg Thr Gly Lys Val Lys Ser Pro Pro Pro Cys Glu Ala Leu Lys Ile Phe Pro Ile Arg Ile Glu Asp Asn Asp Val Leu Val Asp Phe Glu Ala Gly Tyr Leu Ala Pro ポリペプチドV Met Ile Asp Thr Ile Ala Ile Ile Gly Ala Gly Leu Ala Val Arg Arg Leu Arg Ala His Cys Arg Gln Gly Tyr Glu Gly Arg Ile His Leu Leu Gly Asp Glu Ser His Gln Ala Tyr Asp Arg Thr Thr Leu Ser Lys Thr Val Leu Ala Gly Glu Gln Pro Glu Pro Pro Ala Ile Leu Asp Ser Ala Trp Tyr Ala Ser Ala His Val Asp Val Gln Leu Gly Arg Arg Val Ser Cys Leu Asp Leu Ala Asn Arg Gln Ile Gln Phe Glu Ser Gly Ala Pro Leu Ala Tyr Asp Arg Leu Leu Leu Ala Thr Gly Ala Arg Ala Arg Arg Met Ala Ile Arg Gly Gly Asp Leu Ala Gly Ile His Thr Leu Arg Asp Leu Ala Asp Ser Gln Ala Leu Arg Gln Ala Leu Gln Pro Gly Gln Ser Leu Val Ile Val Gly Gly Gly Leu Ile Gly Cys Glu Val Ala Thr Thr Ala Arg Lys Leu Ser Val His Val Thr Ile Leu Glu Ala Gly Asp Glu Leu Leu Val Arg Val Leu Gly His Arg Thr Gly Ala Trp Cys Arg Ala Glu Leu Glu Arg Met Gly Val Arg Val Glu Arg Asn Ala Gln Ala Ala Arg Phe Glu Gly Gln Gly Gln Val Arg Ala Val Ile Cys Ala Asp Gly Arg Arg Val Pro Ala Asp Val Val Leu Val Ser Ile Gly Ala Glu Pro Ala Asp Glu Leu Ala Arg Ala Ala Gly Ile Ala Cys Ala Arg Gly Val Leu Val Asp Ala Thr Gly Ala Thr Ser Cys Pro Glu Val Phe Ala Ala Gly Asp Val Ala Ala Trp Pro Leu Arg Gln Gly Gly Gln Arg Ser Leu Glu Thr Tyr Leu Asn Ser Gln Met Glu Ala Glu Ile Ala Ala Ser Ala Met Leu Ser Gln Pro Val Pro Ala Pro Gln Val Pro Thr Ser Trp Thr Glu Ile Ala Gly His Arg Ile Gln Met Ile Gly Asp Ala Glu Gly Pro Gly Glu Ile Val Val Arg Gly Asp Ala Gln Ser Gly Gln Pro Ile Val Leu Leu Arg Leu Leu Asp Gly Cys Val Glu Ala Ala Thr Ala Ile Asn Ala Thr Arg Glu Phe Ser Val Ala Thr Arg Leu Val Gly Thr Arg Val Ser Val Ser Ala Glu Gln Leu Gln Asp Val Gly Ser Asn Leu Arg Asp Leu Leu Lys Ala Lys Pro Asn
17. The following polypeptides I, II, III, I
V, and benzenedioxygenase containing V. Polypeptide I Met Ser Ser Ser Ile Lys Glu Val Gln Gly Ala Pro Val Lys Trp Val Thr Asn Trp Thr Pro Glu Ala Ile Arg Gly Leu Val Asp Gln Glu Lys Gly Leu Leu Asp Pro Arg Ile Tyr Ala Asp Gln Ser Leu Tyr Glu Leu Glu Leu Glu Arg Val Phe Gly Arg Ser Trp Leu Leu Leu Gly His Glu Ser His Val Pro Glu Thr Gly Asp Phe Leu Ala Thr Tyr Met Gly Glu Asp Pro Val Val Met Val Arg Gln Lys Asp Lys Ser Ile Lys Val Phe Leu Asn Gln Cys Arg Gly Met Arg Ile Cys Arg Ser Asp Ala Gly Asn Ala Lys Ala Phe Thr Cys Ser Tyr His Gly Trp Ala Tyr Asp Ile Ala Gly Lys Leu Val Asn Val Pro Phe Glu Lys Glu Ala Phe Cys Asp Lys Lys Glu Gly Asp Cys Gly Phe Asp Lys Ala Glu Trp Gly Pro Leu Gln Ala Arg Val Ala Thr Tyr Lys Gly Leu Val Phe Ala Asn Trp Asp Val Gln Ala Pro Asp Leu Glu Thr Tyr Leu Gly Asp Ala Arg Pro Tyr Met Asp Val Met Leu Asp Arg Thr Pro Ala Gly Thr Val Ala Ile Gly Gly Met Gln Lys Trp Val Ile Pro Cys Asn Trp Lys Phe Ala Ala Glu Gln Phe Cys Ser Asp Met Tyr His Ala Gly Thr Met Ser His Leu Ser Gly Ile Leu Ala Gly Me t Pro Pro Glu Met Asp Leu Ser His Ala Gln Val Pro Thr Lys Gly Asn Gln Phe Arg Ala Gly Trp Gly Gly His Gly Ser Gly Trp Phe Val Asp Glu Pro Gly Met Leu Met Ala Val Met Gly Pro Lys Val Thr Gln Tyr Trp Thr Glu Gly Pro Ala Ala Asp Leu Ala Glu Gln Arg Leu Gly His Thr Met Pro Val Arg Arg Met Phe Gly Gln His Met Thr Ile Phe Pro Thr Cys Ser Phe Leu Pro Ala Ile Asn Thr Ile Arg Thr Trp His Pro Arg Gly Pro Asn Glu Ile Glu Val Trp Ala Phe Thr Leu Val Asp Ala Asp Ala Pro Ala Glu Ile Lys Glu Glu Tyr Arg Arg His Asn Ile Arg Thr Phe Ser Ala Gly Gly Val Phe Glu Gln Asp Asp Gly Glu Asn Trp Val Glu Ile Gln Lys Gly Leu Arg Gly Tyr Lys Ala Lys Ser Gln Pro Leu Asn Ala Gln Met Gly Leu Gly Arg Cys Arg Pro Asp His Pro Asp Phe Pro Gly Asn Val Gly Polypeptide II Met Val Gly Trp Thr Cys Met Cys Arg Arg Arg Ala Glu Val Pro Ser Pro Asp Ile Tyr Leu Glu Ile Thr Ile Met Thr Asn Pro Ser Pro His Phe Phe Lys Thr Phe Glu Trp Pro Ser Lys Ala Ala Gly Leu Glu Leu Gln Asn Glu Ile Glu Gln Phe Tyr Tyr Arg Glu Ala Gln Leu L eu Asp His Arg Ala Tyr Glu Ala Trp Phe Ala Leu Leu Asp Lys Asp Ile His Tyr Phe Met Pro Leu Arg Thr Asn Arg Met Ile Arg Glu Gly Glu Leu Glu Tyr Ser Gly Asp Gln Asp Ile Ala His Phe Asp Glu Thr His Glu Thr Met Tyr Gly Arg Ile Arg Lys Val Thr Ser Asp Val Gly Trp Ala Glu Asn Pro Pro Ser Arg Thr Arg His Leu Val Ser Asn Val Ile Val Lys Glu Thr Ala Thr Pro Asp Thr Phe Glu Val Asn Ser Ala Phe Ile Leu Tyr Arg Asn Arg Leu Glu Arg Gln Val Asp Ile Phe Ala Gly Glu Arg Arg Asp Val Leu Arg Arg Ala Asp Asn Asn Leu Gly Phe Ser Ile Ala Lys Arg Thr Ile Leu Leu Asp Ala Ser Thr Leu Leu Ser Asn Asn Leu Ser Met Phe Phe polypeptide III Met Lys Asn Ala Arg Leu Phe Leu Ile Ala Ile Gly Val Phe Tyr Ile Ile Asn Leu Ile Gly Thr Leu Pro Phe Ser Thr Leu Gly Leu Phe Gly Arg Met Tyr Pro Gly Val Glu Leu His Val Gly Ala Pro Ile Phe Thr Leu Leu Gln Asp Ala Trp Ala Val Val Gly Leu Gln Leu Gly Ala Ile Gly Ala Val Ala Leu Trp Gly Ala Arg Asp Pro Gly Arg Tyr Arg Ala Val Ile Pro Val Val Ile Ala Thr Glu Val Val Asp Gly Leu Trp Asp Phe Tyr Ser Ile Val Trp Ser His Glu Ala Leu Trp Phe Gly Leu Val Thr Leu Val Ile His Val Leu Trp Ile Gly Trp Gly Leu His Ala Trp Arg Ala Trp Arg Arg Asn Arg Polypeptide IV Met Lys Phe Thr Arg Val Cys Asp Arg Arg Asp Val Pro Glu Gly Glu Ala Leu Lys Val Glu Ser Gly Gly Thr Ser Val Ala Ile Phe Asn Val Asp Gly Glu Leu Phe Ala Thr Gln Asp Arg Cys Thr His Gly Asp Trp Ser Leu Ser Asp Gly Gly Tyr Leu Glu Gly Asp Val Val Glu Cys Ser Leu His Met Gly Lys Phe Cys Val Arg Thr Gly Lys Val Lys Ser Pro Pro Pro Cys Glu Ala Leu Lys Ile Phe Pro Ile Arg Ile Glu Asp Asn Asp Val Leu Val Asp Phe Glu Ala Gly Tyr Leu Ala Pro Polypeptide V Met Ile Asp Thr Ile Ala Ile Ile Gly Ala Gly Leu Ala Val Arg Arg Leu Arg Ala His Cys Arg Gln Gly Tyr Glu Gly Arg Ile His Leu Leu Gly Asp Glu Ser His Gln Ala Tyr Asp Arg Thr Thr Leu Ser Lys Thr Val Leu Ala Gly Glu Gln Pro Glu Pro Pro Ala Ile Leu Asp Ser Ala Trp Tyr Ala Ser Ala His Val Asp Val Gln Leu Gly Arg Arg Val Ser Cys Leu Asp Leu Ala Asn Arg Gln Ile Gln Phe Glu Ser Gly Ala Pro Leu Ala Tyr Asp Arg Leu Leu Leu Ala Thr Gly Ala Arg Ala Arg Arg Met Ala Ile Arg Gly Gly Asp Leu Ala Gly Ile His Thr Leu Arg Asp Leu Ala Asp Ser Gln Ala Leu Arg Gln Ala Leu Gln Pro Gly Gln Ser Leu Val Ile Val Gly Gly Gly Leu Ile Gly Cys Glu Val Ala Thr Thr Ala Arg Lys Leu Ser Val His Val Thr Ile Leu Glu Ala Gly Asp Glu Leu Leu Val Arg Val Leu Gly His Arg Thr Gly Ala Trp Cys Arg Ala Glu Leu Glu Arg Met Gly Val Arg Val Glu Arg Asn Ala Gln Ala Ala Arg Phe Glu Gly Gln Gly Gln Val Arg Ala Val Ile Cys Ala Asp Gly Arg Arg Val Pro Ala Asp Val Val Leu Val Ser Ile Gly Ala Glu Pro Ala Asp Glu Leu Ala Arg Ala Ala Gly Ile Ala Cys Ala Arg Gly Val Leu Val Asp Ala Thr Gly Ala Thr Ser Cys Pro Glu Val Phe Ala Ala Gly Asp Val Ala Ala Trp Pro Leu Arg Gln Gly Gly Gln Arg Ser Leu Glu Thr Tyr Leu Asn Ser Gln Met Glu Ala Glu Ile Ala Ala Ser Ala Met Leu Ser Gln Pro Val Pro Ala Pro Gln Val Pro Thr Ser Trp Thr Glu Ile Ala Gly His Arg Ile Gln Met Ile Gly Asp Ala Glu Gly Pro Gly Glu Ile Val Val Arg Gly Asp Ala Gln Ser Gly Gln Pro Ile Val Leu Leu Arg Leu Leu Asp Gly Cys Val Glu Ala Ala Thr Ala Ile Asn Ala Thr Arg Glu Phe Ser Val Ala Thr Arg Leu Val Gly Thr Arg Val Ser Val Ser Ala Glu Gln Leu Gln Asp Val Gly Ser Asn Leu Arg Asp Leu Leu Lys Ala Lys Pro Asn
JP3284795A 1991-04-16 1991-10-30 Benzene dioxygenase gene Expired - Fee Related JP3001694B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3284795A JP3001694B2 (en) 1991-04-16 1991-10-30 Benzene dioxygenase gene

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8417091 1991-04-16
JP3-84170 1991-04-16
JP3284795A JP3001694B2 (en) 1991-04-16 1991-10-30 Benzene dioxygenase gene

Publications (2)

Publication Number Publication Date
JPH053785A JPH053785A (en) 1993-01-14
JP3001694B2 true JP3001694B2 (en) 2000-01-24

Family

ID=26425232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3284795A Expired - Fee Related JP3001694B2 (en) 1991-04-16 1991-10-30 Benzene dioxygenase gene

Country Status (1)

Country Link
JP (1) JP3001694B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111500A1 (en) * 2000-05-31 2002-08-15 Selifonov Sergey A. Preparation of 4-hydroxy-3[2H]-furanones
WO2005085435A1 (en) * 2004-03-04 2005-09-15 Marine Biotechnology Institute Co., Ltd. Process for producing picolinic acid compounds

Also Published As

Publication number Publication date
JPH053785A (en) 1993-01-14

Similar Documents

Publication Publication Date Title
US5795776A (en) Expression plasmids regulated by an OSMB promoter
JP2763119B2 (en) Microorganism having low acetic acid-producing ability and method for producing useful substance using the same
Yamamoto et al. Purification and Some Properties of a Castor-oil-hydrolyzing Lipase from Pseudomonas sp.
JP3001694B2 (en) Benzene dioxygenase gene
JP4221476B2 (en) Plasmid cloned icosapentaenoic acid biosynthesis genes and cyanobacteria producing icosapentaenoic acid
JPH06277067A (en) Gene dna coding acetohydroxy acid isomeroreductase
WO2000063354A1 (en) Novel amidase gene
AU659237B2 (en) Gene coding for esterase and novel microorganism containing said gene
DE19536506B4 (en) New creatine amidinohydrolase gene, new recombinant DNA and methods of making creatine amidinohydrolase
JP2000217582A (en) Gene coding for enzyme group participating in biosynthesis of icosapentaenoic acid and/or docosahexaenoic acid
AU1986095A (en) Method for increasing plasmid yield
US5217880A (en) L-fucose dehydrogenase gene, microorganism having said gene and production of l-fucose dehydrogenase by the use of said microorganism
JP2000032988A (en) New gene and transformed cell holding its gene
JP3489604B2 (en) 5-aminolevulinic acid synthase gene
JPH11253162A (en) Dna encoding monoamine oxidase
DE3703255A1 (en) DNA SEQUENCES, PLASMIDES AND MICRO-ORGANISMS AND METHOD FOR THE PRODUCTION OF CHINOLIN ACID
JP3085131B2 (en) Genes involved in the esterase secretion mechanism
US5922568A (en) Gene participating in the mechanism of secretion of esterase
JP3330670B2 (en) Alkene monooxygenase, gene encoding the same, transformed microorganism and alkene epoxidation method
JP3491695B2 (en) Method for producing N-acylneuraminic acid aldolase
JP2000253888A (en) Pecinic acid lyase gene
DE3711883A1 (en) GENETIC CONTROL UNIT AND CLONING AND EXPRESSION SYSTEM
Corstjens et al. Cloning, Nucleotide Sequencing, and Computer Analysis of the complete L. discophora SS-1 mofA gene
JPH0731480A (en) Dna fragment coding l-glutamyl-trna reductase
JPH0779775A (en) Nad(h) bonding type oxidation and reduction disproportionation enzyme and its gene

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees